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PREFACE 
 
 
 
 
The calcium phosphate materials are of considerable interest to scientists from many 
fileds such as biology, mineralogy, chemistry and medicine. The reason for this interest is 
very clear since hydroxyapatite (as a member of calcium phosphate family) forms the mineral 
component of bones and teeth. It was found that hydroxyapatite is involved in the 
mineralization process, which opened new research attention on bone graft substutute 
materials using calcium phosphates. As a contribution to the this field of research, we have 
introduced a research project which focus on a recently developed manufacturing process, 
known as the sol-gel method. Using this method we believe we can form the ceramics in new 
shapes with well expressed porosity, which is an important property of the bone graft 
substitute material.     
This work is a small attempt for the world`s contribution to the development of bone 
graft substitute material. The main mission of our research project was to synthezise a 
resorbable material based on calcium phosphate ceramics: hydroxyapatite silica-based 
ceramic and hydroxyapatite/tricalcium phosphate (known as biphasic) calcium phosphate 
silica-based ceramic. Our study introduces in the first chapter a literature review beginning in 
1800’s to the present day on biomaterials, its problems in replacing parts of the human body, 
and the classification of ceramic materials. This section also includes a discussion about 
medical usage of hydroxyapatite and tricalcium phosphate ceramics and reasons for 
investigating biphasic calcium phosphate ceramic. Next, we provide background information 
on bone structure, its composition and the processes of bone formation and remodelling, and 
classification of bone graft materials. In chapter three, we discuss the existing methods for 
synthesis of calcium phosphate powders as well as the problems related to the manufacturing 
of these ceramics. In addition, chapter three briefly indicates the chemistry of hydroxyapatite 
and tricalcium phosphate. 
We continue in the following chapter with an explaination of the manufacturing 
process of calcium phosphate silica-based ceramics and the results of their related properties 
which include: viscosity, thermal stability, porosity and shrinkage, and mechanical testing. In 
the last two chapters, results of the in vitro and in vivo performances of our ceramic samples 
are presented  as well as their relationship to the main application of these materials - for 
biomedical purposes. Lastly, we discuss the obtained results of the use of these calcium 
phosphate ceramics in non-loading and load-bearing implantation sites in mini pigs.  
Since the early 1890s calcium phosphates have been used medically in bone repair, 
because it was thought that these materials might stimulate osteogenesis (i.e. the formation 
and development of bony tissue). Years later calcium phosphate materials have not come to 
fashion as bone substitute materials, for the attention was paid mostly to metals and polymer 
materials. A great progress in the mediacal use of calcium phosphates was made between 
1970s and 1980s with the discovery that these materials are osteoconductive, i.e. they can 
guide bone formation on their surfaces and can facilitate a chemical bonding with the newly 
formed bone.  
The osteoconductivity was found when calcium phosphates were introduced into 
bioglasses and glass-ceramics, or were applied as hydroxyapatite ceramic, tricalcium 
phosphate ceramic and biphasic calcium phosphate ceramics. Since then, a series of calcium 
phosphate-based biomaterials including bioglass, glas-ceramics, different calcium phosphate 
ceramics, calcium phosphate cements, calcium phosphate coatings and bioactive composites 
with calcium phosphates have been developed. The areas of main medical applications of the 
above mentioned biomaterials are in dentistry, maxillofacial sugery and  spinal surgery.  
Twenty-first century is believed to be the golden age for synthetic bone grafts and 
substitutes. Therefore the attention of many scientist is dedicted to the manufacturing of ideal 
bone graft substitute material, which can give the patiens superior outcome and can eliminate 
the donor-associated problems, since almost all bone grafts used currently by thousand of 
surgeones are autogenous (taken from the same patient). Hydroxyapatite is one of the few 
materials that are classed as bioactive, meaning that it forms bond with the surrounding bone, 
unlike other materials such as alumina and zirconia, which are identified as foreign materials 
and become encapsulated by fibrous tissue when implanted. Tricalcium phosphate is another 
material which is considered as biomaterial. Its usage in biomedical fields has overtaken the 
use of hydroxyapatite for many years, nevertheless it is thought that tricalcium phosphate due 
to its high solubility cannot facilitate new bone formation. 
As a result of the trends in the research field on bone graft materials, we have focused 
our attention on bioceramic using both hydroxyapatite and tricalcium phosphate powders. We 
believe that the combination of highly soluble tricalcium phosphate and the more favourable 
for bone ingrowth hydroxyapatite together with a certain amount of silica, will provide a 
better solution to the overwhelming demand for bone graft substitute materials. 
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CHAPTER ONE 
 
Introduction 
 
 
1.1 Literature review 
 
   
 The use of certain materials as constituents of surgical implants is nothing new. 
Substitutions of bone parts for repairing seriously damaged portions of the human body are 
documented since the pre-Christian era. Bronze or copper were then chiefly utilised, probably 
in the circumstances requiring the assembly of fractured bone parts. It was well known, for 
instance, that in the Inca civilisation some operations were carried out, even delicate ones, 
where bone fragments removed during such operations were subsequently replaced in their 
original position. Unfortunately, the technology in which materials other then bronze and 
copper were considered as substances suitable for implantations was not developed until the 
mid-nineteenth century.  
Prostheses were therefore, as a rule, only external. Nevertheless, medical science had 
already made progress as to anticipate serious attempts to repair body parts by means of 
foreign materials. Following a logical structure in terms of compatibility, based on the 
analogy between the composition of ivory and of bone, in 1889 Gluck applied an ivory 
prostheses by using a colophony-based cement for anchorage. In the following years, around 
1902 Jones interposed a gold capsule between the articular heads, which is a remarkable 
achievement that had long-term success. This concept had emerged that in order to obtain a 
successful result, a chemically more inert and consequently more stable material was needed. 
By 1915, it was already possible, contrary to what is commonly believed, to carry out 
studies on substrata of flame-sprayed vitreous melts (Norf, 1915). This track was 
subsequently abandoned owing to difficulties in finding devices capable of spraying melted 
glass at that time. In 1923 Smith-Petersen developed a well-organised program directed 
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towards achieving a practical and stable athroplasty. At first he employed glass capsules, 
which however, proved brittle. Then, he turned to a type of celluloid, which is no longer on 
the market today, and produced an excessive tissue reaction. At last he discovered the 
Vitallium alloy which, compared with all the materials employed until then, displayed such 
qualities of mechanical resistance and chemical inertia that it became the material of choice.  
The first metal prostheses made of Vitallium alloy were produced by Bives-Wills in 1938 and  
then by Bursch in 1939. The latter used self-polymerizing methyl methacrylate for their 
fixation. 
Until 1960, the situation remained substantially unchanged, though it was realized that 
the metal to metal contact was deleterious on account of ensuing corrosion. By the late 1960s 
there was widespread use of polyethylene, which had been already introduced and used since 
the early 1950s (Scaglietti, 1951). Unfortunately Lavor-Gnin found as a result of tests 
conducted on guinea pigs that plastics too, including high-density polyethylene, had a 
carcinogenic power which might have cast some doubts on the long-term tolerability of some 
materials commonly used in orthopaedic surgery. Therefore, Boutin (1972) therefore decided 
to turn to materials presenting no particular biological drawback and directed his attention to 
substances such as alumina, zirconia and calcium aluminate. From dense sintered Al2O3, 
prostheses were prepared, that produced such favourable results in many applications that 
their usage is practically everlasting.        
Nicolini (1973) started some promising experiments with glass ceramics, which had 
many characteristics that proved better then those of the numerous materials already utilized. 
As a result, bioactive-glass-producing technology was started in 1971 by the Hench and 
Broemer groups.  They used compositions, which are still being adjusted, to serve as coatings 
for metal prostheses to achieve simulated natural anchorage without renouncing the positive 
mechanical properties of the metal body. The incidence of orthopaedic interventions has 
increased enormously among the population since man entered the industrial era. The use of 
self-operating machines and the necessity for manual intervention are the main causes of the 
steady increasing number of accidents as production rhythm intensifies and interactions 
multiply. Furthermore, the moral awareness of everybody`s right to existence, which has 
improved life conditions and led to progress in the fields of social and medical security, also 
implies an attempt to rehabilitate those who are subject to congenital malformations, who in 
the past would have led a life of much lower quality. 
 For this reason the interventions aimed at diminishing, alleviating damaged or 
replacing missing limb parts as reliable as possible. Intervening in the human body has always 
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been regarded as a factor disturbing a natural unity, and consequently has sometimes been 
subjected to a sort of sacred interdict. When a foreign substance is introduced into a tissue, 
between the tissue and the substance is a physiological interaction which is mediated through 
a biochemical chain, often unknown and long, which in many cases tries to assimilate the 
substance. 
 
 
 
1.2 Problems in replacing parts of the human body  
 
 
Throughout the  human history, surgery had found widespread support because it has 
always complied with the philosophical principle, which is universally accepted since the 
ancient times, that individual life must be safeguarded. As man increasingly improved his 
knowledge of nature, curiosity and necessity brought him to learn to control his own nature by 
applying those same criteria that have proved valid for the knowledge of the external world.  
When a part of a machine breaks, wears, or becomes useless, recourse is generally made to a 
new substitutive piece capable of restoring the original function; this concept can be also 
extended to the human body. In this case, however, it is important to be morally aware that 
this body belongs to a human being and is not merely a special kind of device.  For this reason 
the guidelines involved in organ substitution must be extremely clear: one aspect is the nature 
of the substance from which the substitute piece is made, and another is the quality of 
functional simulation exhibited.  
In general, a substance constituting an object able to substitute an original living part 
of the body is called a “biomaterial”. A comprehensive definition of this term was 
enunciated in 1982 at the NIH Consensus Development Conference (Galletti and Boretos, 
1983) on the clinical Applications of Biomaterials as follows: “any substance, other then a 
drug, or combination of substances, synthetic or natural in origin, which can be used for 
any period of time, as a whole or as a part of a system, which treats, augments or 
replaces any tissue, organ or function of the body”. At the European Society for 
Biomaterials Consensus Conference held in Chester, UK, in 1986 there was significant 
disagreement with this definition and the following new simple definition was agreed: 
”Biomaterial – a non-viable material, used in a medical device intended to interact with 
biological systems” (William, 1987b). A synonymous term is  “biomedical material”, 
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which indicates a substance, generally in solid consistency, useful for manufacturing an 
object. The object with its shape and structure, may consist of either living or non-living 
materials. The living materials are cells, cell-colonies, and tissues taken from one or more 
individuals, generally soon after death, including skin, bone, cornea and even whole organs 
such as liver and heart.  Devices made from non-living materials and placed in the body are 
called “ implants”, or “implantable devices” (1). 
The expression “surgical implant” is frequently used to denote an implant placed into 
its desired location by means of a surgical procedure. Important in surgical implants is the 
host response to the biomaterial given by surrounding tissue, which is the reaction of a living 
system to the presence of this implanted material. For this purpose, the following restricted 
definition of biomaterial might be useful: “A non-viable material used for medical 
purposes and interacting non-adversely with the living system”. When no interaction 
occurs, the material is called “inert” or “bioinert”. However,  the implanted materials 
behaving in this manner do not actually in practice exist, inert or bioinert has quite often give 
rise to extremely weak interactions. Some important types of interaction, whereby the 
material constituting the implanted device is subject to modifications, are (1): 
 
• Biodegradation, that is, gradual breakdown of a material mediated by specific biological 
and/or biochemical activity 
• Bioresorption, that is, the removal process through cell activity and/or through 
dissolution by continuos ionic diffusion of the material constituting the device body when 
placed in a biological environment, and  
• Bioactivity, that is, the behaviour of a material (called a bioactive material) designed to 
induce a specific biological activity.     
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1.3 Classification of ceramic biomaterials 
 
 
A strong interest in the use of ceramics for biomedical engineering applications 
developed in the late 1960`s, exemplified by the work of Hulbert and co-workers (Hulbert 
et.al 1982-1983). Although, the interest reached a plateau during the late 1970`s and early 
1980`s, there is now an increased pace of activity in the field of bioceramics. In the 
Consensus Conference of the European Society for Biomaterials held in Chester, 1986 there 
was an agreement for the definition of bioceramics: ”a bioceramic, is a ceramic, used as a 
biomaterial”. The development of ceramic material applications in biomedicine has 
concentrated mostly in orthopaedics and dentistry. Orthopaedic bioceramics provide the 
advantage of chemical similarity to natural skeletal materials. As with orthopaedic materials, 
dental applications for ceramics are attractive due to chemical similarity between engineered 
ceramics and natural dental materials. 
 
   J. F. Shakelford (2) has classified the conventional bioceramics by their primary chemical 
constituents: 
 
 Alumina-based ceramics - This is the first bioceramic widely used clinically. It has good 
strength, modest fracture toughness, high wear resistance, good biocompatibility and 
excellent corrosion resistance. The clinical applications of alumina-based ceramic include: 
hip replacement surgery, knee prostheses, bone segment replacements, bone screw, 
middle ear bone substitutes, corneal replacements. In dentistry alumina has been used in 
various dental implants, including blade, screw, jaw bone reconstruction and post 
configurations. 
 Zirconia-based ceramics - Zirconia has become a popular alternative to alumina as a 
structural ceramic because of its substantially higher fracture toughness. Zirconia, in fact, 
has the largest value fracture toughness of any monolithic ceramic. The main application 
filed of zirconia-based ceramic is in the load-bearing surgery. 
 Mixed ceramic oxides - A variety of simple mixed ceramic oxides were evaluated in the 
pioneering studies of bioceramics in the 70`s. CaO. Al2O3, CaO. TiO2 (Perovskite) and 
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CaO. ZrO2 as both porous and non-porous implants were used in soft and connective 
tissue for up to 9 months. Although such studies proved to be reasonably successful and 
helped to establish the basic understanding of the utility of ceramics in biomedicine and 
the role of porosity in their function, simple alumina ceramics generally performed better 
in implantation studies.  
 Silicate ceramics and glasses - Silicates represent the dominant category of the traditional 
ceramics and glass industries. These materials are economical due to the abundant 
availability of raw materials and they provide adequate mechanical, thermal and optical 
properties for a wide range of traditional and advanced materials applications. With the 
development of Bioglass by Hench and co-workers the biomedical applications of 
noncrystalline silicate glasses has increased. Bioglass implants based on composition 
labeled 45S5 (containing 45 wt% SiO2, 24,5 wt% CaO, 24,5 wt% Na2O and 6 wt% P2O5) 
have been successfully applied in a variety of dental and medical applications: ear bones 
surgery, denture wearers, maintenance of jaw bone, restoration of bone next to teeth etc. 
 Glass-ceramics - Glass-ceramics are usually called the “sophisticated form” of crystalline 
ceramics. Both stages glass and ceramic give excellent advantages: due to the glass stage 
the material can be formed into a complex shape economically and precisely by 
conventional glass-forming technology, due to the ceramic stage is the crystallization, 
which gives fine-grained microstructure with little or no residual porosity. Such a 
microstructure tends to provide optimal mechanical performance in a ceramic. Glass-
ceramic products typically have good resistance to mechanical shock due to the 
elimination of stress-concentrating pores. Conventional glass-ceramics are based on 
composition systems such as Li2O-Al2O3-SiO2, which produce crystalline phases with 
exceptionally low thermal expansion coefficients and resistance to thermal shock.  Glass-
ceramics for biomedical applications are more typically based on compositions similar to 
Bioglass system. Ceravital (low-alkali silica glass-ceramic) has been used as implants in 
middle-ear surgery, Apatite-Wollastonite glass-ceramic has been developed in Japan and 
been used successfully in hundreds of patients in replacing part of the pelvic bone and in   
vertebral surgery. An easy-to-machine silica-phosphate glass-ceramic has been produced 
in Germany, which contains phlogopite (a type of mica) and apatite crystals.  
 Ceramic-matrix composites - Ceramic-matrix composites are proving to have even higher 
values of fracture toughness, comparable to that in some common structural metal alloys. 
As with silicate ceramics and glasses, the more common ceramic-matrix composite used 
in industry are not necessarily appropriate for biomedical applications. In addition to the 
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advantage of improved fracture toughness, design goals in developing ceramic-matrix 
composites for biomedicine have focused on increasing flexural strength and strain to 
failure – a good example is an Apatite-Wollastonite glass-ceramic containing a dispersion 
of tetragonal zirconia which has a bend strength of 703 MPa and a fracture toughness of 4 
MPa.m 
-2
.  
 Hydroxyapatite - For many years hydroxyapatite did not come to fashion as a biomaterial, 
nevertheless its obvious chemical similarity to bones. Hydroxyapatite, Ca10(PO4)6(OH)2, 
is the primary mineral content of bone representing 43% by weight. It has the distinct 
physiochemical advantages of stability, inertness and biocompatibility. The relatively low 
strength and toughness of hydroxyapatite, however, produced little interest among 
researchers when the focus of attention was on bulk structural samples. Some of the 
applications of hydroxyapatite ceramics are summarised in Figure 1.1. 
 Other calcium salts – tricalcium phosphate (TCP) with a chemical formula Ca3(PO4)2 has 
been used as a bioceramic as early as 1920. This ceramic salt tends to stimulate the 
formation of immature bone but before used to be described as an example of 
unsuccessful bioceramic (Hulbert et al., 1982-83). Today, TCP remains as a useful 
bioceramic and a good example of the “resorbable” category of bioceramics. Most of the 
applications of TCP ceramics are in conjunction with HA ceramic.  
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Figure 1.1: Variety in the applications of HA ceramic 
 
 
 
 
Hydroxyapatite 
HA/collagen nanocomposite (3) 
HA cement with tetracycline (4) 
HA/acrylate suspension (5) 
Glass reinforced HA 
HA/TCP composite (6) 
Biphasic ceramic/collagen 
HA/sol-gel glass biphasic 
material (7) 
Pressed HA specimens (8) 
Highly porous HA blocks (9) 
Plasma sprayed HA onto Co-Cr 
alloy 
Plasma sprayed HA onto Ti-6Al-
4V alloy 
HA/ bone morphogenetic protein 
(10) 
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1.4 A short overview of the medical usage of hydroxyapatite and tricalcium 
phosphate ceramics 
 
 
Calcium hydroxyapatite Ca10(PO4)6(OH)2 is the principal calcium phosphate used for 
biomedical application. Several investigators have shown that the crystalline planes of 
hydroxyapatite in the bioceramic matched those of hydroxyapatite in the mineral phase of 
bone and that biological apatite was deposited directly on the ceramic surface. Bulk HA has 
been used with success in a variety of applications (Fig.1.1, p.8). 
Tricalcium phosphates Ca3(PO4)2, are probably the most bioactive calcium phosphate 
ceramics. Their high degree of solubility compared with HA has indicated their use in areas in 
which a high degree of bioactivity is desired. This may include the coating of dental and 
orthopedic prostheses as well as in bulk form for use in dental, orthopaedic, and plastic 
reconstructive applications. Unfortunately the high degree of bioactivity may cause the 
material to be completely resorbed without a concomitant deposition of bone. This is a 
problem in certain dental applications, where resorption of the material leads to a clinical 
failure. Cutright et al. first investigated the use of tricalcium phosphate ceramics in the tibias 
of 48 rats. They observed that bone was deposited directly on the ceramics, and that no 
adverse tissue reaction was observed. The high resorption rate was evident in these early 
studies. The authors estimated that biodegradation of the ceramic was 95 % complete at 48 
days after implantation (11). 
Le Geros reviews the uses and clinical results of -tricalcium phosphate in dentistry. 
In some cases, such as a periodontal osseous defects, TCP was reported to have a little benefit 
in repair of the defect. Metsger, Driskell, and Paulsrud reported that only 50 % of human 
patients had complete bone fill when the material was used to fill bony defects (11). Since 
dental uses of TCP did not show much promise, orthopaedic uses were investigated. In many 
of the studies in which TCP was used to fill segmental defects in dogs, filling of the defect 
with bone occurred whether TCP was used or not. Investigation of -tricalcium phosphate 
granules for filling defects after tumor removal in humans was reported by Bucholz, Carlton 
and Holmes (11). They showed that these materials were effective in this application and that 
subsequent fracture did not occur. Betha-tricalcium phosphate granules were also implanted 
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with orthopaedic prostheses in hopes that they would stabilize the prostheses and encourage 
bone formation. Berry et al. reported that the interface bond strength between the implant and 
host bone was not increased by the addition of TCP. Fitzgerald et al. reported that the ceramic 
granules formed a barrier to bony ingrowth of the prostheses (11). Due to problems with 
resorption of TCP without associated deposition of bone, TCP is rarely used clinically. It is 
useful in applications in which bioactive materials are used as a drug delivery system.  
  
 
 
1.5 Reasons for investigating biphasic calcium phosphate ceramics  
 
 
Biphasic calcium phosphate ceramics consist of both -tricalcium phosphate and 
hydroxyapatite. A material with ideal biodegradibility would be replaced by bone as is 
degraded. However, when used as biomaterial, the rate of biodegradation of TCP has been 
shown to be too fast. To slow the rate of biodegradation, biphasic calcium phosphate 
ceramics, consisting of HA and TCP have been investigated. Hubbard (11) was the first to 
investigate ratios of HA/TCP for the use as a bone graft substitute in 1974. These composite 
ceramics offer several distinct advantages over either phase as described above. HA has been 
characterized as relatively bioinert compared with tricalcium phosphate ceramic. Although 
tricalcium phosphate ceramic phase is more bioactive, it may be quickly resorbed without 
subsequent bone formation. The biphasic material has the ability to provide a scaffold for new 
bone ingrowth due to the presence of the HA phase, as well as the ability to promote 
osteogenesis due to the presence of the bioactive -tricalcium phosphate phase. 
Recent in vivo studies indicate that the biodegradation rate of BCP ceramics depends 
on the ratio of TCP to HA in the compound (12). The calcium phosphate ceramics containing 
a greater amount of TCP phase showed greater biodegradation. Along with the 
biodegradation, the HA crystals with Ca/P ratio similar to that of bone-apatite precipitated 
around the calcium phosphate ceramics containing the TCP phase. Sintered HA ceramics 
revealed no noticeable biodegradation after implantation. Osteoconductibility was not 
significantly different between BCP, TCP, and HA. In addition, an in vitro dissolution study 
on commercilaly available calcium phosphate materials revealed that the BCP ceramics which 
contained a higher amount of TCP component dissolved more rapidly. In static physiological 
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solutions (which do not change during the immersion period), calcium and phosphate ions in 
the solutions may reprecipitate on to the calcium phosphate ceramics. Due to its greater 
stability, the HA in BCP acts as a seed material in physiological solutions.     
Some studies on the effect of TCP materials (some tests were made with TCP as bulk 
materials, or granules, or most recently as a phosphocalcic hydraulic cement) on osteoblasts, 
which have been investigated in vitro and in vivo, showed controversial results, depending on 
study design and tested material. Some studies indicate a good bonding between tricalcium 
phosphate and bone, whereas other studies confirm soft tissue interpositions. J. Handschel et 
al. (13) have reported that no direct bone contact was found around the TCP particles, when 
the study was taken in a non-loaded bones – calvaria of Wistar rats. In their study they 
concluded that TCP is hardly resorbed and not osteoconductive in a non-loading model. The 
phase composition of biphasic calcium phosphates may affect their solubility, as reported by 
Daculsi (14) - BCP solubility depends on HA/TCP ratio, the lower the ratio, the higher the 
solubility. 
In the light of the current literature, we have decided that using hydroxyapatite silica-
based ceramic and comparing it with biphasic calcium phosphate silica-based ceramic would 
be useful in order to better understand the behaviour of these ceramics in vivo when implanted 
in Goettinger mini pigs animal model.  
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CHAPTER TWO 
 
Structure and composition of bone. Bone formation 
(Osteogenesis) and remodelling. Bone grafts 
 
 
 The goal of this chapter is first to define specific what are bones and its bone mineral. 
Next, an overview of previous research projects and their findings are presented to better 
understand the bone formation process, where a discussion over its three main steps is 
included. Lastly, this chapter contains a brief presentation of the bone remodelling process, its 
five distinct phases, and a brief overview of the bone grafs.  
 
 
 
2.1 Bone structure 
 
 
 In the literature, the bone material is defined in several ways by scientist and accepted 
in the scientific community. For example, Pritchard defined bone as follows: the bone is a 
type of specialized cementious tissue, characterized by cells with long branches (osteocytes), 
hosting cavities (lacunae) and thin channels (canaliculi), and the bone has a dense and hard 
matrix consisting of groups of collagen fibres within an amorphous boundary substance 
(cement) impregnated with calcium phosphatic complex (1). The bone is not only a unique 
mineralized connective tissue that provides the structural support for the body, but it is also a 
storehouse for essential ions. The skeleton is a repository for 99 % of the body´s calcium, 80 
% of the phosphate, and a major proportion of the body`s stores of magnesium, sodium and 
carbonate.  
The bones of adult skeleton consists of cortical (or compact) and cancellous (or 
trabecular) bone. Cortical bone is dense or compact bone. It constitutes 85% of the total bone 
in the body, and is relatively most abundant in the long bone shafts of the appendicular 
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skeleton. Loss of cortical bone is the major factor for fractures that occur in the hip. Although 
cancellous bone constitutes only 15 % of the skeleton, the changes that occur in this type of 
bone determine whether the clinical features of osteoporosis will occur. The adult skeleton is 
steadily moving in a dynamic state, being continually broken down and reformed by the 
coordinated actions of osteoclasts and osteoblasts. This turnover or remodelling of bone 
occurs in focal and discrete packets throughout the skeleton. There are sequence of cellular 
events responsible for remodelling, which are locally controlled possibly by an autoregulatory 
mechanism. These sequences are always the same: osteoclastic bone resorption followed by 
osteoblastic bone formation to repair the defect. The bone formation is an extremely complex 
process, which is not well understood.  
One of the most unique and important aspects of the bone formation process is the 
biological mineralization of the bone proteins to form a mineralized matrix. In 1987, a 
research by Posner has provided a recent review of the nature of bone mineral and the process 
of mineralization, which is still an area of controversy. The long-standing body of scientific 
knowledge suggest that mineral is initially deposited as amorphous calcium phosphate, which 
is the initial solid phase formed at neutral pH. This phase is randomly and poorly ordered. 
When following deposition of amorphous calcium phosphate, a series of solid-phase 
transformation steps occur that led to poorly crystalline hydroxyapatite as the final stable solid 
phase. The initiation of mineralization is probably caused by heterogeneous nucleation, that 
are actively binding calcium, phosphate and calcium phosphate complexes at the nucleation 
site in the matrix, rather then simple precipitation, which would result in a random 
organization of the crystals. Thus, it is possible that poorly crystalline calcium carbonate-
containing hydroxyapatite is deposited in mature bones, rather than an amorphous calcium 
phosphate or hydroxyapatite (15).  
 
 
 
2.2 Organic and mineral composition of bone 
 
 
Another researchers such as Ravaglioli (Ravaglioli, 1992), proposed that there are 
mainly two salts formed and dispersed within the organic fraction of bone – calcium 
triphosphate and hydroxyapatite. The crystallized mineral fraction is practically 
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hydroxyapatite, in a crystalline form, that constitutes the framework providing the principal 
mechanical characteristics of bone. Approximately, one-third from the weight of the organic 
portion of compact bones is composed of dry free fats, while the remainder are divided into 
collagen, cementing substances, and cells. This remaining organic weight comprises 90-95 % 
of collagen protein fibres. The collagen protein fibres are sclero-proteins of jelly-like 
consistency, that are the main constituent of the organic fibrils found in such cartilaginous 
sections as those of the skin and of connective tissues. Collagen is chemically characterized 
by a high content of aromatic amino acids. These collagen fibrils are considered the 
elementary units of fibres and can be observed only by means of electron microscope 
techniques (Fig. 2.1). Many closely connected aggregates of such fibrils build fibre, which 
can be identified under the light of an optical microscope. Under polarized light one can see 
thin sections of bone disclose a definite relationship between the orientation of the apatite 
crystallites and the direction of collagen fibres. When the crystallites are placed lengthways 
parallel to collagen, their length corresponds to approximately one-third of 640 Å, which is 
the average fundamental unit of repetition of collagen fibrils. In addition, it has been observed 
that HA crystallites locate themselves also around and between fibres.  
 
 Figure 2.1: Network of collagen fibers 
running closely to the ceramic surface, 
scanning electron micrograph, x3000 
 
 
Collagen fibres are surrounded by bone 
with a supporting substance referred to 
as “cement”. This organic cement, along 
which bone mineralizes, fills the spaces 
between fibrils. Such natural or organic 
cement is highly homogenous and 
amorphous, since it appears non-
structured even at the highest resolution limit of electron microscopes. Although the chemical 
composition of cement is not definitely known, its nature largely consists of protein 
complexes.          
Moreover, when evaluating the properties of bone, one should not miss the 
characteristics of its composition, especially those relative to its mineral part and particularly 
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in a view of the possible application of implants made of theoretically suitable materials. 
From this point of view, apatites and the compounds that may be associated with them are of 
fundamental importance, primarily in relation to the physical chemistry of hard tissues. The 
mineral components of these tissues are in the first place calcium phosphates, among which 
hydroxyapatite or HA with chemical formula Ca10(PO4)6(OH)2 -  which is known as the most 
important compound. Bones, in fact, contain HA crystallites about 40 μm in length within 
tissue. Each elementary cells contains two stoichiometric units; the Ca
2+
 ion occupies two 
non-equivalent lattice positions. In the first one, with multiplicity 4 it co-ordinates 9 oxygens 
belonging to PO4
3-
 tetrahedral groups, and these co-ordination polyhedrons are joined together 
so as to form chains along the direction of the c-axis (Fig. 2.2). Halogens and hydroxyl appear 
to be located at the top of the cell in the projection normal to co,  but their co-ordinate with 
respect to this axis is still uncertain.  
 
Figure 2.2: Diagram of the apatitic structure 
(from Ref.1) 
 
 
The arrangement of the –OH groups into unit 
cell packing is of biological significance, since 
the structural difference between better and 
worse arranged OH
-
 groups. These arranged 
OH
- 
groups produce the stacking forms, that are 
the main cause of the stability to increase in the 
direction of fluorapatite. As a result, this means that pure hydroxyapatite does not have a good 
structural order, but rather disorder. Bones, containing apatites richer in F
-
 grow more rapidly, 
and have crystals of greater size compared with corresponding less fluoride-rich specimens. 
The chemistry of hydroxyapatite will be explained in the next chapter. 
It is increasingly evident that HA may undergo a variety of modifications. Accurate 
transmission electron microscopy tests have displayed an ordered arrangement of the apatite 
mineral of bone, with slightly lower computed unit-cell values. Such tests have suggested that 
at the surfaces of HA crystallites the more developed exposed planes are those [223] and not 
the fundamental ones. This can be due to the easier mechanism of attraction in the interaction 
with the enzymatic carriers of the PO4
3-
, OH
-
, and Ca
2+
 ions, for example alkaline 
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phosphatase, calmoduline, and others known and unknown. On the other hand, further factors  
may  be involved that may interfere with the crystallographic arrangements of bony HA. For 
example, traces of elements such as Si, Al, Fe, have been found in the macropores of 
implanted pieces of pure HA ceramic, and the mechanism of their accumulation is unknown. 
These elements are also involved in the biochemical accumulation for the equilibrium of 
blood iron. One further replacement is that resulting from the interaction with CO2. It can be 
admitted a substitution mechanism for the PO4
3-
 group rather than for F
-
, OH
-
, Cl
-
 ions with 
regard to the space volume. 
Yet another researcher Foresti (Foresti et al., 1980) found that biological apatite 
exhibits some marked characteristics of liability to alteration.  The results of many other 
researchers indicate a significant difference between biological apatites and mineral 
hydroxyapatites. It was in fact suggested that of all substituted ions, the Mg
2+
 is the one 
inducing the formation of -TCP (Ca3(PO4)2) (Blumental et al. 1975). X-ray diffractions of 
HA preparations containing 4 to 6% carbonate indicate a behaviour very similar to that of 
mineral part of bone. Moreover, the heating of this preparation to beyond 700°C shows HA to 
be associated to -TCP. The X-ray diffraction of HA containing Mg
2+
 conversely 
demonstrates that such preparations are crystalline to a very small extent, and that their 
heating gives rise to a full transformation into -TCP, with Ca
2+
 partially replaced by Mg
2+
 
(then called -TCMP, betha tricalcium-magnesium phosphate). 
Another further phosphatic component of hard tissues is calcium orthophosphate, or 
OCP, also called monophasic tetracalcium triphosphate - Ca4H(PO4)3 2.5H2O. There is a 
discussion as to whether it is present in bone as a distinct crystal phase or as “defective 
apatite” hydrated through a complex substitution of hydronium ions (H3O
+
) for Ca
2+
 in the 
stoichiometric formula. Optical, structural, and chemical properties prove OCP to be 
structurally correlated with HA, even though the two salts are not isostructural. This 
characteristic proves that epitaxial growths of one compound on the other are very easy to 
obtain by means of a sort of solid solution between the two compounds, which consist of 
planes (each corresponding more closely to either of the two pure compounds) bound by 
layers of water molecules. It is in fact commonly assumed that osteoblasts start their bony 
mineralization at pH 7.5 by an excretive process that leads to the production of OCP as a 
precursive substance that spontaneously converts itself into HA, which is more stable at those 
pH values. The equilibrium between HA and OCP is twofolded and is determined by the 
possibility of coexistence between crystals possessing a different habitus and undergoing two 
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different HA-forming processes. Crystals and steps of HA result from an either partial or 
complete OCP hydrolysis, whereas a direct precipitation will produce HA needles.    
Some apatites found in nature exhibit a composition very similar to that of bone, as 
well as properties and crystallographic structure that correspond to those of the components 
present in bone. The ease with which adventitious substances and other foreign elements are 
incorporated into bone matrix has made their exact determination difficult, for these 
substances are simply adsorbed at the surface of crystals and are chemically combined in the 
crystal structure of calcium phosphate.  
 
 
Figure 2.3: X-ray powder diffraction pattern of natural bone (note the difference with Fig. 
3.2 from Chapter 3) 
 
 
The size and shape of bone apatite crystals have been measured by direct observation 
and by indirect calculations employing X-ray diffraction line broadening. The literature on 
this subject is confusing for several reasons.  Size and shape of the mineral particles change 
with species, age and disease, and a single specimen contains a range of particle sizes and 
shapes (Fig. 2.3). In addition, different measuring techniques may yield different average 
values of polydisperse samples. A representative study of bone from femurs of man, ox and 
rabbit, using X-ray diffraction and dark field electron microscopy, concluded that mineral 
particles are probably plate shaped. The particles were 50-60 Å in the smallest dimension and 
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the largest had a mean value of 320-360 Å, a standard deviation of 130-190 Å, and ranged up 
to about 1100 Å. In a given species the average crystal size is smallest at formation, 
increasing to maturity, and then has a levelling of this growth process. Concomitant with 
increase in crystal size is an improvement in chemical perfection. The earliest bone crystal is 
Ca- and OH-deficient and H-containing. With ripening, the bone crystal aproches, but never 
reaches, the perfect hydroxyapatite formula. When heated to the appropriate temperature bone 
apatite produces pyrophosphate groups and -Ca3(PO4)2, which is an evidence that bone 
mineral is a Ca-deficient, CO3-containing, submicroscopic hydroxyapatite (1).     
In the formation and maturation of bone mineral there is a considerable evidence that, 
as noted earlier, an unstable amorphous calcium phosphate is the first mineral deposited. It 
was concluded that only a portion of this amorphous precursor phase transformed to a poorly 
crystallized, CO3-containing, Ca-deficient bone apatite, while the remainder appeared to 
persist as a separate amorphous phase even in mature bone. In a more recent study (16), the 
amount of amorphous mineral remaining in mature bone was estimated by comparing the X-
ray radial distribution function (RDF) of mature rabbit cortical bone with that of mixture of 
amorphous calcium phosphate and CO3-containing apatite. Considering the accuracy to which 
these RDF`s can be determined, is was estimated that in such a 2-phase model, mature bone 
could contain at most 10 wt % of an amorphous phase. Thus, amorphous mineral could exist 
in significant quantities in bone, either as a transient intermediary, or as a stable phase and 
would be undetectable by radial distribution function method.   
 
 
 
2.3 Bone formation and bone remodelling 
 
 
The process of bone formation (osteogenesis) involves three main steps: 
1. The production of the extracellular organic matrix (osteoid) 
2. Mineralization of the matrix to form bone 
3. Bone remodelling by resorption and reformation 
 
Firstly, the cellular activities of osteoblasts, osteocytes, and osteoclasts are essential to 
the process of bone formation. Osteoblasts synthesize the collagenous precursors of bone 
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matrix and also regulate its mineralization. As the process of bone formation progresses, the 
osteoblasts come to lie in tiny spaces (lacunae) within the surrounding mineralized matrix and 
are then called osteocytes. The cell processes of osteocytes occupy minute canals (canaliculi) 
which permit the circulation of tissue fluids. To meet the requirements of skeletal growth and 
mechanical function, bone undergoes dynamic remodelling by a coupled process of bone 
resorption by osteoclasts and reformation by osteoblasts.    
Bone formation can occur via three related to each other processes. The process of 
endochondral bone formation, as occurs in embriogenesis, begins when mesenchymal stem 
cells (MSCs), progenitor cells that can differentiate into bone or cartilage-forming cells, start 
to differentiate into chondrocytes and secrete a cartilaginous matrix. During this time the cells 
continue to divide. As they pass through various lineage states, they secrete different 
molecules and eventually lose the capability to profilerate. Shortly after the appearance of the 
first bone, the chondrocytes surrounded by the periosteum enter the final stage of 
development and become hypertrophic chondrocytes, which produce proteins that are 
important in calcification of the matrix. At this time, phagocytic cells degrade some of the 
bony periosteum and resorb some of the interior matrix. To this point, the tissue is completely 
avascular, but following matrix resorption, the first capillares begin to appear. The cells that 
migrate into the hypertrophic cartilage work to create a highly vascularized marrow cavity. At 
this point, new set of MSCs begin to differentiate into osteoblasts that proliferate and form a 
bone matrix on the calcified cartilage. The bone produced by this process is immature woven 
bone. This type of bone is rich in osteocytes (mature bone cells) and has small collagen 
fibrils, which are oriented randomly. The spaces around blood vessels in woven bone are 
extensive. This bone will be remodelled to form lamellar bone, which is more organized and 
has superior mechanical properties.                                                                                                   
Endochondral bone formation produces both long and short bones in the body. Flat 
bones usually develop via intramembranous ossification, which differs from the previous 
process in that no cartilaginous model is formed. Instead, MSCs differentiate into layers and 
then begin to produce a matrix that includes blood vessels and more MSCs. These MSCs 
differentiate into osteoblasts and begin to secrete bone matrix.  
A third type of bone development, called appositional formation, occurs during the 
enlargement of bones and during remodelling. In this case, osteoblasts attach to existing bone 
and secrete matrix, often in layers. All these three types of formation occur constantly and a 
particular bone can be formed through any combination of them. As any type of bone 
formation occurs, the predominant collagen matrix secreted by the osteoblasts undergoes 
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calcification. As osteoblasts are separated by calcifying matrix, they are entrapped in spaces 
called lacunae. These entrapped osteoblasts are now called osteocytes and they gradually lose 
the ability to produce matrix.  
These cells communicate with other osteocytes via long processes (canaliculi), which 
are organized before calcification. Mineralization of woven bone occur 24-74h after creation 
of the matrix. There are two steps to matrix mineralization: including nucleation of calcium 
phosphate crystals, followed by crystal growth. Nucleation can occur either heterogeneously 
or homogeneously. Homogeneous nucleation is the formation of crystals due to 
supersaturation of the local environment with the appropriate ions. Heterogeneous nucleation 
occurs only at surfaces where the interaction between the surface and the ions lowers the 
interfacial energy requirement so that nucleation can proceed at concentrations less than that 
of supersaturation. The main example of this in bone calcification is found with collagen-
mediated deposition. After nucleation, amorphous calcium phosphate may be the first 
precipitate, which is then converted to octacalcium phosphate and finally to hydroxyapatite. 
After either type of nucleation forms the first small crystals, they quickly grow from the 
whole regions in the collagen molecules to the overlap regions, where they are aligned along 
the fiber axis.  
As woven bone is formed and calcified, it is remodelled to form mature lamellar bone. 
On a larger scale, both woven and lamellar bone can be found in either cancellous or cortical 
bone. Lamellar bone is generated more slowly than woven bone and is less mineralized. 
Collagen fibers are thicker and have a preferential orientation, which alternates between 
layers and lamellae. Collagen fibrils extend between lamellae, thus increasing the bone`s 
strength. A final stage of remodelling converts some concentric lamellar bone to Harvesian 
systems (secondary osteons). The lamellae closest to the blood vessel are removed and new 
bone is added concentrically. At the interface between the new and the old bone is the cement 
line, a sheath of calcified mucopolysaccharides. Due to overlapping of areas of bone with 
differently oriented collagen fibers, lamellar/Harvesian bone is less flexible than woven bone. 
In concentric lamellar bone, the orientation of the osteons provides strength in tension and 
compression. When a lamellar bone does break, it usually occurs along cement lines rather 
than across osteons. Summarizing all the events that happen throughout bone remodelling, 
five distinct phases of remodelling process can be distinguished. These are:   
1. Resting state: the surface of the bone is lined within active cells. Former osteoblasts are 
trapped at osteocytes within the mineralized matrix. 
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2. Activation: Hormonal or physical stimuli signal mononuclear monocytes and macrophages 
to migrate to the remodelling site and differentiate into osteoclasts. 
3. Resorption: Osteoclasts begin to remove the organic and mineral components of bone and 
form a cavity of characteristic shape and dimensions called Howship`s lacuna in trabecular 
bone and a cutting cone in cortical bone. When the cavity reaches a depth of about 60 μm 
from the surface in trabecular bone and about 100 μm in cortical bone, resorption at that 
location ceases. 
4. Reversal: Osteoclasts disappear and mononuclear macrophage-like cells smooth the 
resorbed surace by depositing a cement-like substance that will bind new bone to old. Pre-
osteoblasts begin to appear. 
5. Formation: Differentiated osteoblasts fill in the resorption cavity and begin forming new 
osteon in a two-stage process. First, they deposit osteoid (mostly collagen type 1). The rate of 
matrix apposition is initially very rapid and the osteoblasts are columnar and densely packed.  
Mineralization of the osteoid begins when the cavity has been filled to 20 μm.  With the onset 
of mineral apposition, the rate of mineralization exceeds the rate of matrix apposition and 
continues, with a substantially lower rate, even after the termination of matrix synthesis, until 
the bone surface returns to its original resting state (17). 
 
 
 
2.4 Bone grafts 
 
 
Bone is the second most frequently transplanted tissue in humans. In the United States 
alone, it is estimated that over 200,000 operations per year are performed that requires bone 
grafts (Statistic from 1986 according to Ref. 11). Surgical uses of bone grafting materials 
include surgical intervention of ossesous nonunions, restoration of the structural integrity of 
bone after trauma, and filling defects following bone tumor removal. Different grafting 
materials and graft substitutes are available for use as bone grafts. Here the comparisons 
between several bone graft materials in use are given (11): 
 Autograft  - Autograft bone is bone taken from the patient who will receive it. This 
material may be obtained from the iliac crest, rib, fibula, or tibia (Fig. 2.4). Autogenous 
cancellous bone graft is currently the preferred graft materials for several reasons. First, it 
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is biocompatible and nonimmunogenic since it comes from the same person. Second, it 
will not transmit a disease to the recipient. Third, it has osteogenic potential since cell on 
the trabecular surface of the graft become active after transplantation. Although  
autogenous bone grafts offer several advantages over other bone grafts, they also have 
some distinct disadvantages. In the first place, autogenous bone grafts can only be taken in 
limited amounts from the iliac crests or ribs. Even when a small amount is taken, 
morbidity at the donor site due to the surgical procedure to remove the graft may be 
significant. Furthermore patients requiring autogenous bone grafts are often in groups 
found to be at greatest risk of complication, due to the metabolic disease, and offering 
poor quality bone for reconstruction.  
 
 
 
Figure 2.4: Bone graft donor sites (from Ref. 18)  
 
 Allograft  - Another graft material, which is the second most frequently used in surgeries 
requiring a bone graft, is allograft. Allogeneic bone is defined as bone taken from a donor 
of the same species. Allograft bone has several advantages over autogenous bone. First, 
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the materials is available in an unlimited supply. Massive reconstructive surgeries, such as 
hip athroplasty revisions, are often performed with allograft bone. Second, there is 
currently no other graft material or graft substitute that can restore structural integrity to 
the site as satisfactorily as massive allografts. Allogeneic bone grafts have also some 
disadvantages. First, the materials do not have the osteogenic potential of autogenous 
bone grafts. Allografts may also elicit immunological response when implanted. This 
reaction depends on the degree of mismatch between the transplanted tissue and the host 
tissue. The problems with immunogenic response and concomitant resorption are 
suspected as the major cause for fracture of the allografts, which has been reported to 
occur in roughly 10% of the cases. Allograft bone may provide initial stability as a bone 
graft, but inherent problems may cause graft rejection, resorption, and loss of  
biomechanical stability at the graft site. Further, the ossibility of transmission of disease 
makes the use of allografts precarious.    
 Xenograft – Xenografts are explored as bone grafts to compensate the limitations of 
autografts and allografts as mentioned above. They can be prepared including frozen calf 
bone, freeze-dried calf bone, decalcified ox bone, deproteinized bone, and anorganic bone. 
The main disadvantage of xenografts is that they are antigenic and nonosteoinductive. To 
facilitate osteogenesis, many researchers have added components of autograft or 
autologous marrow to the xenograft.         
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CHAPTER THREE 
 
Methods for synthesis of calcium phosphate powders 
 
 
 
Several methods currently exist for the preparation of synthetic calcium phosphate 
powders, which are used in the fabrication of bulk ceramics. The techniques used in each of 
these methods have advantages and disadvantages in the fabrication of bulk ceramics. For 
instance, the properties of these powders, such as impurities, particle size, and particle 
morphology effect the ability of the powders to become bonded in sintering process. 
Therefore, the realization of ideal compressive strengths of the ceramics for many loading 
applications depends directly on the properties of the starting calcium phosphate powders. 
Secondly, the properties of the final ceramic product such as phase present (purity) and 
calcium solubility are influenced by the properties of the initial calcium phosphate powders 
(11). This chapther will focus firstly on the following methods for preparation of calcium 
phosphate powders: hydrothermal method, solid-state reactions, precipitaion method and sol-
gel method. Secondly, discussed are the problems related to the fabricaion of calcium 
phosphate ceramics and how the sintering and pore size influence the medical application of 
these ceramics. Very briefly we have mentioned about the chemical nature of hydroxyapatite 
and tricalcium phosphate. Lastly, we tried to give here an explanation why do we investigate 
biphasic calcium phosphate ceramics.  
 
   
 
3.1 Hydrothermal conversion of corals (calcium carbonate) 
 
 
One technique that can be used to produce the synthetic calcium phosphate materials is 
known as the hydrothermal conversion of coral skeleton which forms predominantly 
hydroxyapatite. The use of corals from the group of Goniopora, Porites, Favites and 
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Lobophyllia has been investigated. These coral specimens consist of 99 % calcium carbonate 
in the form of aragonite and 1% organic material. After being ultrasonically cleaned to 
remove the organic material, this material is heated at elevated temperature and pressure in 
the presence of aqueous phosphate solutions. This causes a replacement of phosphate ions for 
the carbonate ions and changed the crystal structure to calcium hydroxyapatite.  
The porosity of these corals has advantages and disadvantages for implantation 
purposes. One significant advantage was pointed out early in the investigation of the corals 
for use as bone graft substitutes. In 1977, Chiroff et al. (11) observed interconnected pores 
and uniformity of pore size. Further studies showed that certain corals have uniform porosity 
in the range of 500 to 600 μm in diameter, which is known to be advantageous for 
osseointegration. One disadvantage of corals is that the porosity varies only slightly from 46% 
to 48%. The fixed character of porosity can be biologically undesirable in certain instances. 
When converted and unconverted corals are incorporated into the graft site they are slowly 
resorped. The difficulty in obtaining sufficient starting material from commercial sources is a 
disadvantage for this method. Another disadvantage of the substituted corals is the variability 
in the final chemical composition of the ceramic. It is known that ions such as magnesium, 
sodium, chloride, and fluoride, which are present in the seawater and become incorporated 
into the coral, affect sintering parameters of these calcium phosphate implants and may have 
an effect on the biological response. 
 
 
 
3.2 Preparation by solid-state reactions 
 
 
 Another technique for the preparation of synthetic calcium phosphate powder is the 
preparation by solid-state reactions, where the final product is formed by calcination. 
Calcination is the process of heating  a substance to a high temperature, but below its melting 
point, to cause a loss of moisture, reduction or oxidation. Some authors have investigated 
calcining of commercially available dibasic calcium phosphates such as calcium hydrogen 
orthophosphate (CaHPO4, known as monetite) or calcium hydrogen orthophosphate dihydrate 
(CaHPO4.2H2O, known as brushite) to obtain the alpha and beta phases of calcium 
pyrophosphate. Using these same techniques, commercially available tribasic calcium 
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phosphate, Ca3(PO4)2, powders can be calcined to obtain hydroxyapatite, the alpha and beta 
phases of  tricalcium phosphate (TCP), and ratios of these two. 
Furthermore, the extreme variability in the original composition of these commercially 
available powders has frequently led to results that are not reproducible. The method has a 
major disadvantage in that the final product depends on the composition of the starting 
material, which may vary from batch to batch. Thus, the final phase can range from -
tricalcium phosphate to hydroxyapatite, even though the starting powders appear identical by 
X-ray diffraction. In many instances, the commercially available powder is amorphous 
initially, which cannot be detected by X-ray diffraction. It is hypothesized that the 
nonstoichiometry of commercially available powders, as well as the presence or absence of 
water in apatite structure, results in the formation of different phases upon calcining. 
Impurities in the staring powders obtained commercially may hinder the ability of these 
powders to become bonded in the sintering process, thus causing a significant decrease in 
compressive strength, and may affect the biological response to the materials. Because of the 
need for a controlled, predictable, and reproducible biological response to these materials, 
solid-state reactions are rarely used to fabricate calcium phosphate ceramics for biomedical 
applications.    
Recently a new method, called mechanosynthesis for obtaining HA and HA/TCP 
mixtures was developed. Under conditions of mechanical grinding different reactants are 
crushed between a balls or ball and wall whereby they absorb the part of energy provided by 
the collisions, which allows their reaction. Variations of the starting materials, reaction time 
and sintering temperature lead to formation of required calcium phosphate (19).  
 
 
 
3.3 Precipitation methods 
 
 
A third method for obtaining different calcium phosphate powders is via precipitation 
reactions. Calcium orthophosphates, calcium pyrophosphates, tricalcium phosphate, calcium 
hydroxyapatite, and ratios of hydroxyapatite and -tricalcium phosphate can be prepared 
directly or indirectly using precipitation techniques. That is, these phases are precipitated 
directly, or powders obtained from the precipitation reactions can be calcined to yield the 
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desired phases. HA and ratios of HA/TCP can be precipitated at a basic pH using calcium 
nitrate, Ca(NO3)2.4H2O, and ammonium phosphate, (NH4)2HPO4, as starting materials.  
This technique offers the ability to vary pH of the reaction by adding different 
amounts of concentrated ammonium hydroxide (NH4OH), which results in different 
precipitants. Also, the temperature at which the reaction is carried out can be varied, thus 
affecting the size of the resultant precipitate particles. A range of the size of these precipitates 
may be beneficial in sintering since particle size is one of the parameters that affects sintering. 
In addition, variation of the time at which the precipitate is harvested will greatly affect the 
resultant phase obtained. The use of reagent-grade starting material with minimum amounts of 
impurities allows the production of pure starting powders. Impurities in the starting powders, 
as mentioned before, inhibit grain boundary bonding and result in poorly sintered ceramics 
with low compressive strength values. Impurities may adversely affect the ceramic resorption 
or other biological response by effecting changes in solubility. It is known that highly 
substituted apatites elicit a different biological response than calcium hydroxyapatite when 
implanted. Due to the ability to vary reaction parameters and to control the purity of the 
starting powders, precipitation techniques are invaluable and preferred in preparing calcium 
phosphate phases for a variety of biomedical applications. 
Relatively new method, called liquid mix technique, based on Pechini patent was 
developed for synthesis of hydroxyapatite. This Liquid Mix Technique gives a single phase 
hydroxapatite, which is thermally stable in temperature range between 1000°C and 1300°C. 
The method, as described by its inventors allows massive, reproducible and low cost 
production of hydroxyapatite with precise homogenity (20).  
 
 
 
3.4 Sol-gel method 
 
 
One very novel and advantageous method for preparing calcium phosphate powders 
and ceramics is sol-gel method.  In the past 20-30 years this method for synthesis has reached 
great popularity due to its low cost, lower temperatures of making than the traditional 
processing methods and the ability of controlling the surface chemistry of the required 
material. The chemically based process is used for producing not only ceramics, as well as 
glasses, glass-ceramics and composites. Many authors have described the history, theory, 
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processing details and applications of sol-gel processing (Iler, Brinker and Scherer, Hench 
and West). The sol-gel method was used by Jarcho, and many others subsequently, to make 
hydroxyapatite  ceramics. New generation of bioactive glass-ceramics have been made using 
the sol-gel method by Li et al. (21).  
Sol-gel synthesis of HA ceramics has recently attracted much attention. The sol-gel 
method offers a molecular-level mixing of the calcium and phosphorous precursors, which is 
capable of improving chemical homogeneity of the resulting HA to a significant extend, in 
comparison with conventional methods such as solid state reactions, wet precipitation, and 
hydrothermal synthesis. The synthesis of HA requires a correct molar ratio of 1.67 between 
Ca and P in the final product. A number of combinations between calcium and phosphorous 
precursors were employed for sol-gel synthesis. Besides the difference in chemical activity of 
the precursors, such as hydrolysis, polycondensation etc., it appears that the temperature that 
is required to form the apatitic structure depends largely on the chemical nature of the 
precursors. Table 3.1 gives a summerized description of the different research groups who 
synthesised HA via sol-gel route and the variety of precursors used (where Tf is the 
temperature of formation e.g. crystalization of HA phase). 
Once the amorphous or poorly crystalline powders are obtained from the precipitations 
and dried, they can be calcined to yield a calcium phosphate phase that depends on the 
composition of the precipitated powder. Calcining, as mentioned before is a heating below the 
melting temperature, by which the present water and some organic residues are removed. 
Isostatic pressing is another method for compacting the powders. After applying a hydraulic 
isostatic pressure of 25 000 pounds per square inch (psi) for example, the resulted powders 
have an increased compressive strength and decreased porosity due to the packing of the loose 
powders together, which is beneficial for sintering. 
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RESEARCH 
GROUP 
PRECURSORS TF OF HA PHASE AGING TIME 
Gross et al.  Calcium dietoxide-Ca(OEt)2; Triethyl 
phosphate- PO(OEt)3 
Above 600°C – monophasic 
HA 
Not longer than 24 
hours 
Jillavenkatesa 
et al. 
Calcium acetate-Ca(C2H3O2)2; 
Triethyl phosphate - PO(OEt)3 
775°C – mixture of HA and 
CaO 
Further HCl is 
required to eliminate 
CaO 
Brendel et al. Calcium nitrate-Ca(NO3)2.4H2O; 
Phenyldichlorophosphite- C6H5PCl2  
Below 400°C – low purity 
and crystallinity of HA 
powder; above 900°C – pure, 
well-crystallized HA phase  
 
Takahashi et 
al. 
Calcium nitrate- Ca(NO3)2.4H2O; 
Phosphonoacetic acid- 
HOOCCH2PO(OH)2  
700°C– pure HA powder 
with increasing the 
crystallinity to 1100°C 
 
Chai et al. Calcium diethoxide- Ca(OEt)2; 
Triethyl phosphate- PO(OEt)3 
No formation of HA  
Chai et al. Calcium propionate; Triethyl 
phosphate- PO(OEt)3 
500°C – appearnace of HA 
phase 
 
Qiu et al. Calcium nitrate- Ca(NO3)2.4H2O; 
Ammonium dihydrogen phosphate–
NH4H2PO4  
400-1100°C – increasing of 
crystallinity with T 
 
Haddow et 
al. 
Calcium acetate-    Ca(C2H3O2)2; 
phosphoric acid-H3PO4, phosphorous 
pentoxide-P2O5, triethyl phosphite 
Higher than 600°C for 
triethyl phosphite and 
calcium acetate precursors 
 
Lopatin et al.  Calcium nitrate Ca(C2H3O2)2 in 2-
methoxyethanol; N-butil acid 
phosphate  
300°C- poor crystallinity, 
which increased above 500°C  
Impurities of CaO 
and Ca3(PO4)2 
Weng et al. Mixed ethanol sol. of calcium nitrate 
Ca(NO3)2.4H2O and phosphorous 
pentoxide- P2O5 
500°C – highly crystallized 
HA coating 
Heat treatment for 
12-24 hours 
 
Table 3.1: Sol-gel processing of HA powder using different precursors (from Ref.22) 
 
 
 
 
3.5 The effect of pore size and sintering on the biomedical application of 
calcium phosphate ceramics 
 
 
To improve osseointegration of calcium phosphate ceramics in the bony tissue, pores 
are created in the ceramics using different methods. It is well known that pores in range of 
150 to 500 μm are optimally beneficial for bony ingrowth. One of the ways for creating pores 
is so called Hubbard method. This method entails mixing the calcium phosphate powders with 
sized naphthalene. When naphthalene is sublimed out, pores are left behind that retain the size 
of the naphthalene particles. Standard sieves can be used to obtain sized naphthalene particles 
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in the desired porosity range. In the fabricating of porous calcium phosphates during the 
second thermal treatment (i.e. sintering) a shrinkage in porosity size occurs, which must be 
taken into account. The first stage in thermal treatment is to sublime out the naphthalene at 
about 400°C. By adjusting the amount and the particle size of naphthalene, the resultant 
porosity of calcium phosphate ceramics can be varied from 0 % to 70 % (11). 
The second stage of thermal treatment is to effect bonding of the calcium phosphate 
particles. Sintering is a process by which particles become denser (decrease in porosity) when 
subjected to high temperatures, below the melting temperature of the material. Sintering 
parameters for calcium phosphates vary from temperatures of 1000°C to 1300°C and times of 
1 to 24 hours. After the sintering some microporosity in order of a few microns could remain 
in the final material due to the gaps between the sintered particles. According to some authors 
microporosity is not an important factor for osseointegration (e.g. for bone ingrowth), but in 
Chapther 4 we will discuss the different types of porosity of our ceramic samples and how  is 
porosity connected with bone ingrowth and blood vessels circulation. Sintering of calcium 
phosphates increases their density and strength. A wide variety of mechanical properties may 
be obtained due to the variability in the shape, size, and purity of the starting powders, as well 
as the sintering time, temperature and heating/cooling rate for each of the calcium phosphate 
phases. As is typical for many ceramics, the compressive strength of the calcium phosphates 
is quite good. Unfortunately, low values for tensile strength and fracture toughness limit the 
use of calcium phosphates for load-bearing applications.     
Although dense calcium phosphates have superior mechanical properties compared 
with porous calcium phosphates, the lack of porosity does not allow for bony ingrowth or 
osseointegration of the implant. It is also known that mechanical properties decrease as 
microporosity and macroporosity of calcium phosphates increase.  Since calcium phosphates 
are being investigated for use as bone graft substitutes for limited load-bearing situations, it is 
important to consider the mechanical properties necessary for each graft site. Due to the 
ability to tailor-make the calcium phosphates with various sizes and amounts of porosity to 
foster osseointegration, it follows that the mechanical properties will also vary as the porosity 
changes.  
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3.6 Problems related to the manufacturing of calcium phosphate ceramics 
 
 
Researchers in many fields (e.g. calcified tissue research, medicine and dentistry, 
chromatography) involving apatites have a frequent use for synthetic hydroxyapatite as a 
starting, reagent or reference material. However, the differences among preparations reported 
to be “hydroxyapatite” might lead one to wonder whether there really is such a thing as pure, 
stoichiometric hydroxyapatite. Variously prepared hydroxyapatites are widely known to vary 
in many ways. As McDowell et al. (23) commented, “it is well known that hydroxyapatites 
have variable indices of refraction, unit cell dimensions, impurity contents, degrees of 
disorder in the OH position, and may possibly vary in their Ca and OH contents”. Arends and 
Jongebloed (23) have particularly commented on some of the properties of hydroxyapatite, 
which make difficult the preparation of pure stoichiometric HA. These include strong 
tendencies: 
 
 To become nonstoiciometric (e.g., by sustaining Ca or OH vacancies) 
 To take up impurities in the structure, e.g. F, CO3 and H (as HPO4), as well as a long list 
of other elements 
 To form surface complexes, and 
 To be formed in aqueous solutions, via precursors rather then directly.  
 
 
 
3.6.1 Ionic substitutions in the hydroxyapatite lattice 
 
 
One potential method for improving the bioactivity of hydroxyapatite is the 
incorporation of silicon (or silicate groups) into the hydroxyapatite lattice. However, it is 
important that the ionic substitution of silicon does not result in thermal instability of the 
silicon-substituted  hydroxyapatite as this effect upon sintering would result in the 
decomposition of Si-HA to undesirable second phases. In a study by Gibson et al. (24) is 
described the preparation of a new hydroxyapatite-based material by an aqueous precipitation 
route, which contains small level of silica (0.4 wt %) and which retains the HA structure on 
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sintering. Further in this work is shown that the silica substitution gives very small changes in 
the chemical composition and the crystal structure, such as unit cell parameters, which are the 
result of the incorporation of a slightly larger silicate ion in the place of a phosphate ion and 
the loss of some of the OH
-
 groups. 
E. M. Carlisle had examined in early 70`s approximately 5000 electron probes 
quantitatively for silicon, calcium and phosphorous on 50 specimens of normal tibia from 
mice and rats. The findings from her study had shown that silica was localized in active 
calcification sites in young mouse and rat bone. Thus most probably silica is a possible factor 
in bone mineralization (25). Micromolar concentrations of aluminium and silicon ions have 
been reported to stimulate osteoblast proliferation and differentiation; however, high 
concentrations of aluminium have been demonstrated to suppress bone mineral formation 
(26). 
After comparing the results of previously made hydroxyapatite preparations from 
different researchers, we have decided in order to avoid any complications like impurities, 
second phases in the powders, variation in Ca/P ratio etc., to use a commercially supplied 
hydroxyapatite powder which should have constant parameters. We have chosen  
hydroxyapatite powder  supplied from Aldrich (Germany) and tricalcium phosphate supplied 
from Fluka (Germany). As it was already pointed out, the main aim of this study is to check 
the bioresorbability of hydroxyapatite silica-based ceramic and to compare it with 
bioresorbability of biphasic calcium phosphate silica-based ceramic, when both are implanted 
in Goettinger mini pigs animal model.  
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3.7 General chemistry of hydroxyapatite 
 
 
Apatites have the formula Ca5(PO4)3X , where X can be ab F
-
 ion (fluorapatite FAp), 
OH
-
 ion (hydoxyapatite, HA, or OHAp), or a Cl
-
 ion (chlorapatite, ClAp) for example. 
Gerhard reported in 1786 (27),   
  
Figure 3.1: Crystal structure of HA in the a,b-plane 
viewed down the c-axis. The OH
-
 lie in the channel 
formed by Ca
2+
 at the intersection of the four unit cells 
shown. (H- white, O2-red, Ca-blue, P – purple) 
 
 
that the name apatite had been coined by AG Werner 
from the Greek   , to deceive, because it was 
frequently confused with other minerals such as 
aquamarine, olivine, amethyst, fluorite, schorl, etc. The apatite structure is very tolerable to 
ionic substitutions, and for example, Ca
2+
 ions can be partly or completely replaced by Ba
2+
, 
Sr
2+
 or Pb
2+
 ions, and PO4
3-
 by AsO4
3-
 ions. Thus there are lead minerals with the apatite 
structure which include Pb5(PO4)3Cl (pyromorphite), Pb5(VO4)3Cl (vanadinite) and Pb5(As 
O4)3Cl (mimetite). Solid solitions of halide and OH
-
 are of frequent occurrence. 
Coupled substitutions frequently occur in apatites. In these, one ion is replaced by 
another of the same sign, but different charge, and neutrality is maintained by substitutions of 
ions with dissimilar charged or vacancies elsewhere. The CO3Aps (carbonate apatites) are an 
important and complex example that have been the subject of much controversy. These 
carbonate-substituted Aps include the minerals francolite, dahllite and the rock-phosphates, 
and the biological apatites. Nonstoichiometry, with vacant lattice sites, occurs in the 
biological apatites and frequently in synthetic apatites, and considerably complicates their 
crystal chemistry.  Apatites (mostly FAp and CO3Fap) form an important series of minerals. 
They occur as a minor constituent of many igneous rocks, in most metamorphic rocks, 
especially crystalline limestones. The basic apatite structure is hexagonal with space group 
P63/m and approximate lattice parameters a=9.4 and c= 6.9 Å with two formula units 
(Ca5(PO4)3X or Ca10(PO4)6X2) per  unit cell. The values of lattice parameters and refractive 
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indices often depend slightly on the mode of preparation because of frequent 
nonstoichiometry (Fig. 3.1). 
  The large number of different synthetic routes and published preparations 
demonstrates the difficulty of making stoichiometric HA (s-HA). Most of synthetic methods 
have to rely on the assumption that s-HA is the equilibrium phase under the preparation 
conditions used. Although, this may be approximately true, there is no thermodinamic reason 
why an apatitic equilibrium should be exactly stoichiometric. The stoichiometry has been 
determined experimentally by accurate chemical analyses, by calculated cell contents from 
the lattice parameters and by density measurements. What evidence there is, suggests that the 
equilibrium phase is not generally exactly stoichiometric.  
One method that has been used to prepare s-HA is to use accurately stoichiometric 
quantities for the synthetic reaction, and attempt to ensure formation of a single phase without 
unwanted gain or loss of chemical species. Another approach is to use the aqueous system 
Ca(OH)2-H3PO4-H2O at a composition in which HA (assumned to be stoivhiometric) is the 
only stable phase, and to attempt to ensure that the system is in equilibrium. Yet another 
technique is to synthesise a nonstoichiometric HA (ns-HA) under noequilibrium conditions, 
and to process this to give a stoichiometric composition. For example, solid state reactions 
have been used in which samples of nearly stoichiometric compositions are heated to a high 
temperature so that s-HA is formed as the major phase, together with a minor phase (CaO or 
-TCP, depending on whether the Ca/P molar ratio is greater or less than 1.667 respectively) 
in an amount dependent on the departure of the overall composition from s-HA. The minor 
phase is then extracted from the product. A further method is to rely on the easier synthesis of 
a related stoichiometric apatite (s-ClAp or s- BrAp) that can be converted to s-HA. In the 
beginning of this chapter a detailed description of the variation in methods for synthesising 
HA was reported.  
Hydroxyapatite and related materials (e.g. biological apatites) are of great interest 
because of their similarity with the inorganic component of teeth and bone. Typical 
compositions of the inorganic component of enamel, dentine and bone are given in Table 3.2.  
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Component Enamel (wt %) Dentine (wt %) Bone (wt %) 
Ca 37.6 40.3 36.6 
P 18.3 18.6 17.1 
CO2 3.0 4.8 4.8 
Na 0.7 0.1 1.0 
K 0.05 0.07 0.07 
Mg 0.2 1.1 0.6 
Sr 0.03 0.04 0.05 
Cl 0.4 0.27 0.1 
F 0.01 0.07 0.1 
Ca/P molar ratio 1.59 1.67 1.65 
 
Table 3.2: Average composition of the mineral in specimens of human calcified tissues ( from 
Ref. 27) 
 
 
It is obvious that CO2 contents of dentine and bone are similar and significantly higher 
than that of enamel, the magnesium contents of bone and dentine are higher than that of 
enamel, but there is almost twice as much magnesium in dentine as in bone, the Ca/P molar 
ratio of enamel is significantly lower than the ratio for HA (1.667) whilst the Ca/P ratio for 
dentine and bone is approximately equal to the ratio for HA (and can be even higher). As 
would be expected for biological material, the composition of the inorganic component of 
teeth and bones is rather variable, depending on the part of tissue sampled. There are often 
also changes during formation and maturation, and with age and disease. The composition can 
also be species dependent. Figure 3.2 presents the typical XRD spectra of commercially 
supplied hydroxyapatite powder (Aldrich, Germany) heated at 1200°C, which we used as a 
starting material in our experiments. The powder has a well expressed crystallinity and does 
not show decomposition upon sintering.  
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Figure 3.2: X-ray diffraction pattern of commercially supplied hydroxyapatite powder, 
heated at 1200°C 
 
 
 
 
3.8 General chemistry of tricalcium phosphate 
   
 
Tricalcium phosphate (whitlockite) was first described in 1941 as a hydrothermal 
product from a granite pegmatite and named after the mineralogist Herbert P. Whitlock. The 
mineral was reported with a supposed formula of Ca3(PO4)2. As a result the terms whitlockite 
and -TCP have been used interchangeably, but there are subtle structural differences 
between these substances. Tricalcium phosphate occurs in two forms: -TCP, which is the 
higher temperature phase, and -TCP. The -TCP to -TCP transition temperature is 1125°C, 
however, lately another high temperature phase of -TCP was dicovered, which is stable 
above 1430°C and is called super- -TCP (27). 
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 Betha-TCP has the rhombohedral space group R3c with unit cell a=10.439, c=37.375 
Å (hexagonal setting) with 21 formula units per hexagonal unit cell. Figure 3.3 presents the 
typical X-ray diffraction pattern of TCP powder, which was commercially supplied from 
Fluka (Germany) for the purposes of our study.  
 
Figure 3.3:  X-ray diffraction pattern of commercially supplied tricalcium phosphate powder  
 
 
 
The -TCP structure is a distortion of the parent lattice Ba3(VO4)2, with layers perpendicular 
to the c-axis. Because of the size of Ca
2+
 ion, there is reduction in the number of PO4 
tetrahedra in the structure compared to that of the parent lattice and a reduction in the number 
of formula units within its hexagonal unit cell. Two types of Ca sites exist within the -TCP 
unit cell: those known as Ca(5) are fully occupied, while a particular set of cation sites known 
as Ca(4) are only half occupied (28).  
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CHAPTER FOUR 
 
Manufacturing and results from properties examination of 
calcium phosphate silica-based ceramics 
 
 
 
After giving a sufficient background regarding the history of bioceramics, about the 
different methods for synthesis of calcium phosphate powders including the specific 
advantages and disadvantages, the main aim of this chapter is to describe the manufacturing 
process of calcium phosphate silica-based ceramics, which we made in our laboratory. 
Secondly, a detailed discussion of the viscosity behaviour, the thermal stability and the 
mechanical properties of  the ceramic materials is included. Lastly, we will analyse the results 
from the porosity measurements and the thermo-gravimetry  measurements. 
 
 
 
 
4.1 Preparation of calcium phosphate ceramic samples 
 
 
For the purpose of our study we have prepared the samples using the following 
procedure: Tetraethyl orthosilicate (TEOS, which is used as a precursor for silica) was mixed 
with water, ethanol (used as solvent), and hydrochloric acid (HCl, used as a catalyst). The 
molar ratio rw (H2O/Si) was 4. The process is called sol-gel and can be described by the 
following reactions (29):  
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hydrolisis 
                           Si   OR +  H2O       Si   OH +  ROH                                (1) 
esterification 
 
 alcohol condensation 
              Si   OR +  HO   Si         Si   O   Si    +  ROH                           (2) 
alcoholysis 
 
water condensation 
                    Si   OH +  HO   Si        Si   O   Si   +  H2O                            
(3) 
hydrolysis 
 
 
where R is an alkyl group, CxH2x+1. The hydrolysis reaction (Eq.1) replaces alkoxide groups 
(OR) with hydroxyl groups (OH). Subsequent condensation reactions involving the silanol 
groups produce siloxane bonds ( SiOSi) plus the by-product alcohol (ROH) (Eq.2) or water 
(Eq.3).  
Since water and alkoxysilanes are immiscible, a solvent such as alcohol is normally 
used as a homogenizing agent. However, gels can be prepared from silicon alkoxide-water 
mixtures without added solvent, since alcohol produced as the by-product of the hydrolysis 
reaction is sufficient to homogenize the initially phase separated system. In our system, we 
added additionally ethanol, because ethanol improves the homogeneity of the gel, and 
increases the gelling time (30). The molar ratio H2O:Si (rw)  in Eq.1 can vary from less than 
one to over 50, as well as the concentrations of acids or bases can vary from less than 0.01 to 
7M, depending on the desired product. The following net reaction can be shown: 
 
                               nSi(OR)4 + 2nH2O   nSiO2 + 4nROH                                 (4) 
 
where is believed that an rw value of 2 is  theoretically sufficient for complete hydrolysis and 
condensation to anhydrous silica.  
In the experiments we made, the rw had value of 4, but even with the excess of water, 
the reaction of hydrolysis and condensation does not reach completion. Therefore, we 
consider that hydrolysis is finished after the change in solution colour – from translucent to 
transparent, and when the temperature of the reaction (which is exothermal) stopped 
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increasing. It seems that variations in the synthesis conditions (e.g. value of rw, the catalyst 
type and concentration, the solvent, the temperature, and pressure) cause modifications in 
structure and properties of the silicate products. More information about the synthesis, 
properties, structure and variety in applications of sol-gel materials can be found in Ref. 29.  
Once hydrolysis reaction is completed as mentioned above, we immersed the solution 
in cold water to allow the temperature to cool down (around 20°C) and then we added the 
calcium phosphate powders. The cooling of the sol is a necessary step for the production 
cycle of our ceramic samples, because higher temperatures can lead to increasing in the 
gelling rate itself. Furthermore, the aggregation of silica particles is proportional to the 
activation energy and involves a kinetic phenomenon. When the gellation occurs before 
mixing the sol with calcium phosphate powders, the final product will be only silica gel, 
which is not a priority for the purpose of our experiments. The pH value of the sol after 
hydrolysis is 1.8-2.0, and after mixing it with calcium phosphates it arises to 4.8-5.2, which is 
the optimum pH value of the sol, when slow gellation of the system is needed.                        
According to the pH/gelation time dependence we can control gel formation with variations in 
pH, but for our system the pH value is naturally controlled by the addition of calcium 
phosphate powders. As mentioned by Iler (31) “the main step in gel formation is the collision 
of two silica particles with sufficiently low charge on the surface that they come into contact 
so that siloxane bonds are formed, holding the particles together”. This process is guided by 
the catalytic action of hydroxyl ions, or by dehydration of the surface of particles at higher 
pH. This is evidenced by the fact that the rate of gel formation in the pH range 3-5 increases 
with pH and its proportional to the hydroxyl ion concentration. Above pH 6, insufficiency of 
hydroxyl ions no longer guides the rate of gelling. Instead, the rate of aggregation decreases 
because of fewer collisions between particles owing to the increasing charge on the particles, 
and thus decreases with higher pH. The net result of these two effects is a maximum in rate of 
gelling at around pH 6 and stability of sols in the pH range 8-10 (Fig.4.1). 
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Figure 4.1: Effects of pH on gelation time of silica sol (from Ref. 31) 
 
 
 
Silica sol and calcium phosphate powders were mixed using ultrasonic bath, for better 
homogenization and for preventing the formation of particles from unmixed powder. After 
mixing the samples, they were left to dry in ethanol atmosphere for 2-3 days. This is a 
necessary step in manufacturing process, since contact between air and as-prepared samples 
leads to faster drying and cracks on their surfaces. As a result one can get completely 
destroyed materials, which cannot be used for further investigations (i.e. for medical 
application). A consequent heating of the materials for two hours in an air atmosphere was 
performed, using an electrical oven with a temperature of 200°C. Figure 4.2 is a flowchart 
that presents the processing steps followed until the final product was obtained.  
One of the main requirements for bone graft material is to have a certain porosity and 
sufficient pore size to allow bone ingrowth. Following this requirement we completed the 
heating only up to 200°C, because sintering the samples to higher temperatures would lead to 
decreasing of pore volume and pore size. Some investigators have found that sintering up to 
700°C of hydroxyapatite ceramic produces a foreign body reaction after implantation and 
affects the solubility of Ca and P ions (32). 
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Figure 4.2: Preparation diagram of calcium phosphate silica-based ceramic 
 
 
Although, our ceramic samples were not heated to 700 °C (or even more) they did not show 
any foreign body reaction when used in vivo (see discussions about in vivo behaviour in 
Chapter 6). In this study (32) the authors claimed that hydroxyapatite ceramic sintered to 
1100°C has demonstrated superior osteogenetic activity than one sintered at 900°C. Later we 
will come to the discussion about the heat treatment of our ceramic samples, where we will 
provide an useful conclusions regarding sintering and thermal decomposition of HA and BCP 
ceramics.    
 
 
Figure 4.3: View from the ready for 
implantation material (BCP silica-based 
ceramic) in form of “spaghetti” 
 
 
 
 
 
 
 
1. Hydrolisys of TEOS 
 silica sol with pH 1.8 
2. Cooling the sol to 
20°C for 20 min. 
3. Mixing sol and CP 
powders in ultrasonic 
bath, viscosity control 
4. Extrusion through grid 
with d=1 mm 
5. Drying at room temp. 
and EtOH atmosphere 
6. Heating  in air at 
200°C for 2 h 
7. Rinsing with dist. 
water and pH 
adjustment (pH 7.3-7.6) 
8. Drying ceramic 
samples at 100°C for 1h 
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We tested two different bioceramics mixed with silica sol – hydroxyapatite ceramic and 
biphasic calcium phosphate ceramic (Fig. 4.3). The way of preparation of both ceramics is 
equal with the only difference that the rate of gel formation vary, which we found very 
sensitive factor to Si
4+
/Ca
2+
 ratio, thus, time for extruding the ceramic to shape it in the 
desired form (like spaghetti lying in a bowl) is dissimilar. In hydroxyapatite ceramic the 
Si
4+
/Ca
2+
 ratio is 2,6 and the total silica content 24 wt %. In biphasic calcium phosphate 
ceramic we have 1,3 Si
4+
/Ca
2+
 ratio and 16 wt % silica  (Table 4.1)  
 
 
MATERI
AL 
SI
4+
/CA
2+ 
RATIO 
SI CONTENT  
IN WT. % 
RW 
RATIO 
PH OF SILICA 
SOL  
PH AFTER 
ADDING CP  
      HA 2.6 24 4 1.8-2.0 5.17 
     BCP 1.3 16 4 1.8-2.0 4.85 
 
Table 4.1: Production characteristics for hydroxyapatite and biphasic calcium phosphate 
ceramics 
 
 
Recently, there has been a growing interest on the role of soluble silica in new bone 
formation. Many scientists have focused their research on the possible applications of silica 
gels as starting materials for preparation of bioactive glass and glass-ceramics. In our 
laboratory we designed a novel ceramic material which is suitable for bone substitutes and it 
is unique because of its special composition. The decision for choosing silica sol and 
consequent mixing it with calcium phosphate powders is due to the fact that firstly, silica 
plays an important role in biological systems (25), and secondly calcium phosphates (e.g. 
hydroxyapatite and tricalcium phosphate) are the most used ceramics for bone replacement. 
These ceramics have relatively poor mechanical strength. Therefore the combination between 
the silica matrix with higher mechanical strength and calcium phosphates with better 
biocompatibility should give greater result for material with promising future in biomedical 
applications.  
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4.2 Viscosity behaviour of calcium phosphate silica-based ceramic 
 
 
In recent years, the sol-gel process for making ceramics, glasses and composites has 
received considerable attention; investigations on processing and physical properties are 
voluminous. However, rheological chararcterization of sol-gel materials is relatively limited. 
Qualitative rheological considerations are often used to define the point of gelation. For 
example, Sakka  et al. defined the gelling point as the loss of fluidity, i.e. no flow of the sol as 
observed upon tilting the container. Yu et al. defined the gelling time as the time interval from 
the start of aging to time recorded when the surface of the sol remained steady while the 
container was tilted for 2 minutes (33). Unfortunately, the above definitions of the gelling 
point are uncertain and qualitative, making the comparison between different studies difficult. 
The gelling point is often defined as the aging time at which the viscosity of the sol increases 
abruptly. Viscosity measurements have also been used to identify point during the sol-gel 
transition when sols are suitable for various processing operations, e.g. fiber drawing, 
substrate coating, etc. Sacks et al. (33) reported that silica fiber formation was possible when 
the viscosity of the sol was ~ 1-100 Pa.s., and for thin film formation with viscosity between 
1 and 10 Pa.s. Leroy et al. indicated that the optimum condition for ZrO2 fiber drawing 
occurred when the viscosity of zirconium acetate solutions was  ~ 20-50 Pa.s (33).  
As it was mentioned in Paragraph 4.1, determining the viscosity of our material prior 
to extruding it in a shape of spaghetti is very important part from fabricating the ceramic into 
a certain form, especially in the case of extruding, where the process is dependent on the 
gellation time (e.g. viscosity). Rheological flow characteristics were determined using  
Brookfield viscometer with cone cylinder. Steady rotational flow curves (i.e. shear stress , 
vs. shear rate ) were generated by increasing the shear rate from zero to the maximum 
desired value in 30 sec. Immediately decreasing the shear rate back to zero in the same time 
interval was performed. The viscosity was determined using the relation: 
 
	= /                                                                (5) 
 
For the mixture of calcuim phosphates and silica sol, according to the rotational flow curves 
the type of flow behaviour can be specified as a pseudoplastic (the one which displays a 
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decreasing viscosity with increasing of the shear rate) with rheopexy flow (fluid`s viscosity 
increases with time as it is shared at a constant rate), or it is also called shear thinning flow 
behaviour. To examine that our calcium phosphate silica-based mixture has shear thinning 
flow behaviour, would be unnecessary to make viscosity measurements, because it is very 
obvious that the gelation is time dependent. Since this is a very sensitive process, one needs 
more detailed study about the viscosity/time dependence. Figure 4.4 shows the change in 
viscosity as a function of gelling time using share rate of the cone 1 rpm (rotations per 
minute) for biphasic calcium phosphate silica-based ceramic. 
 
 
 
Figure 4.4: Viscosity-time dependence for biphasiccalcium phosphate silica-based ceramic 
 
 
Until 40 minute from the beginning of the measurement the viscosity remains almost 
constant, the fluid has a Newtonian behaviour, which can be due to the low particle-particle 
interactions. Further with aging (respectively with gelling), agglomeration of polysilicate 
species is expected. As in a suspension with agglomerates, this leads to increase in the 
viscosity due to immobilised liquid within the interparticle void space, so the “effective” 
solids loading increases. In the early stages the polysilicate species/agglomerates have 
relatively small volume and the effective solids loading is low. Minimal particle-particle 
interactions exist in the sol mixture, so the flow behaviour remains Newtonian. As aging 
proceeds, large agglomerates (or microgel regions) form and the effective solids loading 
increases rapidly. At low shear rates these microgel regions result in high viscosities. As the 
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shear rate is increased, agglomerate breakdown occurs releasing immobilised liquid and 
resulting in low viscosities due to the decreased effective solids loading. This is reflected in 
the observation of shear thinning flow behaviour.  
Viscosity data often functions as a “window” through which other characteristics of a 
material may be observed. Viscosity is more easily measured than some of the properties that 
affect it, making it valuable tool for material characterization. One of the most obvious factors 
that can have an effect on the rheological behaviour of a material is the temperature. Some 
materials are quite sensitive to temperature, and a relatively small variation will result in a 
significant change in viscosity. Fortunately, our ceramic material when subjected to viscosity 
measurements did not show any temperature sensitivity in the temperature interval 20-30°C. 
The condition of a material during measurement of its viscosity can have a considerable effect 
on the results of such measurement. Variables such as Viscometer model, spindle/speed 
combination, sample container size, sample temperature, sample preparation technique, etc., 
all affect not only the accuracy of the measurements, but the actual viscosity of the material. 
Another factor which may affect viscosity measurements is the homogeneity of the sample.  
Such a tendency of a material to separate into non-homogeneous layers for our sample is not 
observed, for the mixing between silica sol and calcium phosphate powdes was done in an 
ultrasonic bath, and therefore the mixture is very homogenous. Aging phenomena must be 
also considered for time-dependent materials. But changes in the viscosity of many materials 
can occur over time even though the material is not being shared.  
Many materials could undergo changes in viscosity during the process of a chemical 
reaction, so that viscosity measurement made at one time in the reaction may differ 
significantly from another one made at another moment. Here is necessary to notice another 
detail, which might be also of an importance when discussing gellation-time dependence. This 
is the speed of mixing the calcium phosphate powders with the silica sol. As it has been 
shown by the practice, when the speed is too high (too much quantity of powder is mixed at 
once), the gellation occurs faster in comparison with the slower adding the powders into silica 
sol solution. This can be explained by the pH-time dependence, which was already mentioned 
in Paragraph 4.1, i.e. faster adding of calcium phosphate powders causes rapid increase in the 
pH value and dellation occurs in shorter time. The increase of pH value is especially sensitive 
in the interval between 1.8 (the pH of silica sol) and 5.8. It should be stated that viscosity 
measurements are strongly dependent on the volume of the mixture examined,  as well as on 
the environmental conditions. If the system which has to be checked is open, the viscosity 
reaches its high values for shorter time due to evaporation. In closed-measured systems 
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gellation time is longer and respectively viscosity reaches its high value for many more hours. 
All the difficulties related to viscosity measuements, and respectively to the  extrusion of our 
ceramic samples in spaghetti form, once again underlined the importance of materials 
characterization to obtain a better product.   
 
 
 
4.3 Thermal stability of calcium phosphate silica-based ceramics 
 
 
The decomposition of HA at high temperatures is frequently encountered during the 
fabrication of HA ceramics. This inhibits the sinterability of the apatite ceramics and partly or 
completely transforms HA into a mixture of tetracalcium phosphate (TeCP), Ca4(PO4)2O, and 
tricalcium phosphate (TCP), Ca3(PO4)2. If such reaction occurs in the bioceramic material 
under physiological conditions, the mechanical integrity and osteogenetic activity of the 
ceramics is damaged.  
Hydroxyapatite can be prepared by various synthesis methods as it was already shown  
in Chapter 3. The results have shown that the thermal stability of a HA is intrinsically 
dependent on its stoichiometry and the crystal structure. These are, in turn, related to both the 
nature of precursor and synthesis conditions. The optimum thermal stability (up to 1370°C) 
was observed in HA samples prepared by the hydrothermal method and by hydrolysis of 
brushite (34). Before examining the thermal stability of our ceramics, we have tested the 
thermal stability of the starting powders (HA and TCP, respectively) used in the 
manufacturing process of the bioceramics. An XRD pattern of hydroxyapatite powder 
(supplied by Aldrich-Germany) heated at 1200°C shows no decomposition into TCP phase, 
proving that the powder is stoichiometric (Fig. 3.2).      
It was reported by Fang et al. (34) that nonstoichiometric HA decomposes via 
dehydration according to the following reactions: 
 
Ca10-x(HPO4)x(PO4)2-xnH2O  
<700°C>   Ca10-x(P2O7)x(PO4)6-2x(OH)2 + nH2O(g) 
700°-800°C>   (1-x)Ca10(PO4)6(OH)2 + 3Ca3(PO4)2  + xH2O(g)                           (6) 
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The resultants after themal treatment are stoichiometric HA and TCP. At temperatures higher 
than 900°C, further partial dehydration of HA may take place as follows: 
 
              Ca10(PO4)6(OH)2   
>900°C>   Ca10(PO4)6(OH)2-2yOy + yH2O(g)           (7) 
 
According to the above mentioned reactions one should observe a gradual wt. loss before 
700°C, a sharp loss in 700°-800°C region, and a slight and gradual loss above 900°C in the 
TGA thermogram of a nonstoichiometric HA sample. There should not be any sharp loss for 
stoichiometric HA in its TGA curve between 700°C and 800°C. Thus, the TGA curve of our 
HA ceramic heated to 800°C shows once again that the powder which we used for the 
synthesis of the ceramics samples is stoichiometric hydroxyapatite (Fig. 4.5).  
 
    
Figure 4.5:  Thermogravimery 
anlysis (TG) for HA and BCP 
siica-based ceramis performed 
up to 800°C. 
 
 
 
 
 
 
 
On Fig. 4.5 three regions can be recognized: in region a) up to 120°C a sharp sample mass 
loss was detected due to water loss. In region b) from 120-590°C further decrease in sample 
mass is visible involving the release of rest of the water and that of the organic parts (e.g. 
alcohol). The last temperature region c) from 590-800°C shows no changes in the sample 
mass. These results are in accordance with the DTA curves of our samples (Fig. 4.6). Note 
that both ceramic materials have similar behaviour when exposed to TG-TD analysis. 
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Figure 4.6: Differential 
thermal analysis (DTA)  for 
HA and BCP silica-based 
ceramis performed up to 
800°C. 
  
Two exothermic peaks 
appeared on the TDA diagram. 
The first at 100°C is very 
sharp for both HA and BCP 
probes. Still there is a very small difference between the two ceramics, that is that the water 
release from BCP system requires more heat. The second exothermal peak shows again a 
slight difference between HA and BCP samples. In BCP ceramic the release of the organic 
matter and rest of water happened at 250°C, while for HA ceramic the peak position is at 
265°C. Actually, since the dissimilarities from TG-TD analysis of HA and BCP ceramics are 
negligible, the results from both ceramics can be interpreted in the same manner.     
Tricalcium phosphate undergoes also thermal decomposition, which can be expressed 
by the following reaction: 
 
Ca3(PO4)2.nH2O  
680-720°C>   
- Ca3(PO4)2  
1290°C>   - Ca3(PO4)2  
1540°C>  -        
Ca3(PO4)2 superstructured                                                                                                (8) 
 
Over the century the decomposition process of mineral tissues with time has been tested on 
human bones. When X-rayed, these bones revealed the presence of such compounds as 
Ca4P2O9, - Ca3(PO4)2, 
- Ca3(PO4)2 (1). This suggests that the natural decomposition of bone 
develops according to the following reactions: 
 
Ca10(PO4)6(OH)2  

 2Ca2P2O7 + Ca3(PO4)2  + 3CaO + H2O                       (9) 
 
Ca10(PO4)6(OH)2    3 Ca3(PO4)2  + CaO + H2O                                       (10) 
 
2Ca2P2O7 + 2CaO   Ca4P2O9                                                                                                           (11) 
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The thermal stability of our mono- and biphasic ceramics were investigated by XRD 
analysis of the air-quenched samples after heating. The samples were heated at various 
temperatures (600°C, 750°C, 900°C, 1000°C and 1200°C) in air. The firing time for all 
samples at all temperatures was 1 h. After calcination the samples were left in the furnace and 
allowed to cool. XRD data were collected using CuK

 radiation (=1.541Å), over the 2 
range 10-110° with step size of 0.02°. The thermal behaiviour was characterized by the 
decomposition temperature of the HA and BCP ceramic. Since the HA decomposition is 
always accompanied by the appearance of TCP (either in 
- or -form), the minimum 
temperature at which HA or the BCP ceramics were heated and the TCP phase was detected 
from the sample, was recorded as the decomposition temperature of that ceramic. In the BCP 
ceramic where TCP phase exists in the starting material, the TCP amount was determined by 
changes in HA/TCP ratio compared to the one of the staring material. 
 
 
Figure 4.7: XRD spectra of hydroxyapatite ceramics heated between 600°C and 1200°C, (*) 
HA phase; (°) TCP phase 
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Figure 4.7 shows the changes in XRD spectra of HA ceramics upon sintering. With exposing 
the ceramics at temperatures up to 900°C no changes in the XRD spectra can be detected. The 
ceramic consists of hydroxyapatite phase only. At 1000°C the first peaks that belong to the 

TCP phase appeared, at this temperature we therefore have a material consisting of both HA 
and TCP phases, predominating the first. At 1200°C, the decomposition of HA phase into 

TCP probably results into a higher percentage of the 
TCP. According to these results the 
decomposition temperature of our hydroxyapatite silica-based ceramics is 1000°C. Further 
investigations of these ceramics for medical applications should not exceed 1000°C as 
sintering temperature due to these phase transformations, which could lead to completely 
different by its cmposition material.  
Another proof of HA ceramics undergoing thermal decomposition is given by in-situ 
temperature-dependent X-ray diffraction spectra of HA silica-based ceramic made in  DESY 
HASYLAB, Hamburg (Fig. 4.8). The measurement was done at the F2.1 beamline in energy 
dispersive mode. Figure 4.8 indicates the partial phase transition of the HA into 
TCP phase, 
which is retained in the final spectra of the cooled sample at 50°C. The first 
TCP diffraction 
peak appears at 900°C; in parallel the initial HA peaks which start to disappear; at 1200°C the 
pattern corresponds to 
TCP phase.  
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Figure 4.8: Energy dispersive X-ray diffraction pattern of HA silica-based ceramic 
 
 
The picture of biphasic calcium phosphate ceramic undergoing phase transformations 
is more complicated, due to the fact that from the beginning both phases (HA and 
TCP) are 
present in the X-ray diffraction spectra (Fig. 4.9). At 600°C the ratio between HA and TCP 
phases should be 60/40 wt. %, the same as the initial ratio of the prepared samples. Up to 
750°C the X-ray diffraction patterns remain unchanged. With further sintering and increasing 
temperature more peaks form 
TCP phase are observed in the spectra. When the sintering 
temperature has reached 1200°C very few of the characteristic peaks for HA can be detected, 
since most of this phase is transformed into the 
TCP phase.  
The thermal behaviour of hydroxyapatite silica-based ceramic differs from the thermal 
behaviour of biphasic calcium phosphate silica-based ceramic. In the first case we obtained 
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partly transformed hydroxyapatite into tricalcuim phosphate phase, but with the presence of 
HA phase in the spectra at 1200°C, while the spectra of BCP ceramic at 1200°C shows almost 
complete transformation of the HA phase into the tricalcuim phosphate phase. 
 
 
 
Figure 4.9: XRD spectra of biphasic calcium phosphate ceramics heated between 600°C and 
1200°C, (*) HA phase; (°) TCP phase 
 
A number of recent studies have attempted to clarify the transformation of Ca-
deficient hydroxyapatite to 
-TCP. Changes in the size and morphology of the crystallites 
were observed with increasing calcination temperature by Yubao et al. (35). The temperature 
range at which the transformation occurred was established as 650-750°C. The disappearance 
of the HPO4
2-
 bands in the FTIR spectra at this temperature was also observed. A study by 
Gibson et al. (35) indicates a decrease of the crystallite size of calcium-deficient 
hydroxyapatite over the temperature region 600-700°C, followed by a large increase of the 
grain size as the sintering process begins. These results suggest that after the loss of water and 
the transformation into 
-TCP at 710-740°C, no further changes occur. Although no change 
in the symmetry of the 
-TCP formed between 740 and 1100°C was observed, a very unusual 
change in the lattice parameters was observed as the calcination temperature was increased. 
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This change indicated that the structural changes that occur during the transformation from 
calcium-deficient hydroxyapatie to 
-TCP are not complete at 740°C and further changes 
occur between 740 and 1100°C. The structural changes probably involve changes/distortions 
in the PO4 tetrahedra, where three different types of crystallographically non-equivalent PO4 
groups in the 
-TCP structure are reported. These changes are small enough not to affect the 
symmetry, but significant enough to result in changes of the lattice parameters.   
Another research group working with hydroxyapatite/sol-gel glass biphasic materials 
(7) has shown, that by heating of their mixture to 1000°C leads to a decreasing surface area, 
which affects bioactivity, and led to the formation of new crystalline phases such as SiO2, 
wollastonite, - and 
-TC. The presence of quarz and wollastonite can be explained as a 
result of crystallization from the gel-glassy matrix, while the last two phases result from 
thermal decomposition of hydroxyapatite. Since stoichiometric hydroxyapatite does not show 
any decomposition at this temperature according to (7), the reaction observed has to be related 
with the above mentioned interaction with the gel. Although in our hydroxyapatite ceramics 
we have 24 wt % silica, at 1200°C of hydroxyapatite X-ray diffraction pattern we did not 
detect the presence of SiO2 as a single phase. The disagreement comes from the dissimilar 
way of preparation of our ceramic samples and the ones prepared according to (7).         
Biological apatites have also shown decomposition when exposed to higher 
temperatures. Upon heating to 1000°C the bone mineral of most mammals shows significant 
transformation to tricalcium phosphate. In some cases there is no such transformation, and the 
discrepancy is ascribed to greater Ca/P ratios, and lower amount of HPO4
-
 and Mg in human 
bone mineral (36).  
The thermal behaviour of the designed in our laboratories calcium phosphate 
bioceramic was well documented and it is in accordance with the reported phase 
transformations of hydroxyapatite into tricalcium phosphate when heated (1, 7, 34, 35, 36). 
Every disagreement (i.e. phase transformation temperature, percentage of the phases present 
at a certain temperature) between our bioceramics and the materials mentioned in the 
literature is due only to different making procedure, different starting materials and 
conditions. Hydroxyapatite silica-based ceramic is thermally stable until 1000°C, after which 
temperature partly transformates into betha-tricalcium phosphate. Biphasic calcium phosphate 
silica-based ceramic is thermally stable as well at 1000°C. The decomposition of BCP silica-
based ceramic at temperatures higher than 1000°C, indicates a higher presence of the 
tricalcium phosphate phase when compared with HA silica-based ceramic at the same 
temperature. Since the main aim for producing these ceramics is their biomedical application, 
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temperatures higher than 1000°C shoud be avoided in order to prevent the above stated phase 
transformations.  
 
 
 
4.4 Porosity and shrinkage 
 
 
Data on biodegradibility of the different calcium phosphate ceramics (hydroxyapatite, 
tricalcium phosphate, dense or porous) are conflicting. If one studies the experimental 
conditions as reported by many investigatiors, it is clear that not only have a variety of 
surgical procedures and animal models been used to investigate the resorption behaviour, 
crystal structure, and degree and types of porosity, but conditions of manufacture have often 
not been clearly defined. However, factors presumed to govern biodegradation that are most 
often mentioned are molar ratio Ca/P, crystallography and degree of porosity.  
Provision of a suitable macroporous structure is important in order to obtain good 
implant incorporation through rapid vascularisation, bone ingtrowth, and where the implant is 
resorbable, possibly remodelling. Conventional ceramic processing techniques have been used 
to form hydroxyapatite bodies, and several methods of inducing porosity have been described. 
The simplest methods involve the incorporation of compounds that may be volatilized prior to 
sintering. Materials such as naphthalene and calcium stearate can be used. The degree of 
porosity, thus, is controlled by the amount of degradable material added. Porous calcium 
phosphates have been formed by the addition of hydrogen peroxide (H2O2) to the powder 
slurry (37). Both pore size and pore volume are controlled by the quantity of H2O2 added and 
the rate at which the slurry is dried. Such techniques can control the total amount of porosity, 
but the size of pores is scattered around the required mean.  
In order to examine the change in porosity with sintering temperature, we have 
produced samples of hydroxyapatite silica-based ceramics and biphasic calcuim phosphate 
silica-based ceramics with rectangular shape (2.9 x 1,5 x 0.8mm) and heated them between 
200°C and 1200°C. The relative density of the sintered materials was measured by the 
Archimedean method in water. The porosity was calculated according to the following 
equation: 
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                          Porosity % = (0/1) x 100                                   (12) 
 
 where 0 is the density of the dried samples, and  1 is the density of the wet samples. At 
200°C BCP and HA samples posses different porosity – for HA is about 55% and for BCP is 
65% (Fig. 4.10). The porosity of both ceramics remain unchanged until 800°C – the small 
increases at 400°C for HA samples, and at 500°C and 750°C for BCP samples are probably 
related to differences in block´s size between the starting ceramics. Although we have 
produced similar in shape samples there are variations in their size, thus, the changes before 
the sintering temperature can be detected. Starting from 800°C both ceramics showed fast 
decrease in porosity, due to sintering and decreasing of the free space between the crystals. 
The final porosity at 1200°C is different for both ceramics, and it is surprisingly that BCP 
which has higher porosity at 200°C shows lower porosity at 1200°C than HA ceramic. The 
value for BCP ceramic has dropped down to 25%, while the HA ceramic is slightly higher 
than 35% at 1200°C. One of the possible explanations for this result can be the higher amount 
of calcium phosphates in the starting material for BCP ceramic, which upon sintering shows 
tendency for aggregate formation (increase in grain size), therefore the porosity of biphasic 
ceramics depends on the proportions of the two phases – HA and TCP. Not only porosity, as 
well as microstructure and densification ratio of biphasic ceramics can be linked to the 
diffusion phenomena and to the particle coalescence that occur at lower temperature in 
comparison with densification of monophasic ceramic.                  
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Figure 4.10: Change in real porosity of HA and BCP ceramics with temperature 
 
 
     
a)              b) 
 
Figure 4.11: Porosity in μm range (picture a, where scale bar represents 4μm, SEM) and in 
nanometer range (picture b, TEM), which shows the loose packing between the crystallites, 
wrapped by the SiO2-matrix 
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It is generally admitted that 80-100 μm is the minimal pore size for osteoconduction. 
A pore size of 50-400 μm is recommended for metallic implant fixation to provide better bone 
ingrowth than with larger pores of 400-800 μm. Some studies have reported notable bone 
ingrowth for pores smaller than 100 μm, but many authors consider that only pores larger than 
100-150 μm facilitate ingrowth of mineralized bone (38). Therefore, the design of porous 
implant materials with pore size larger than 150-200 μm, appears to be an essential criterion 
for clinical purposes. However, the existence of pores, particularly the macropores (i.e. those 
pore have a few hundred micrometers in dimension), can be accompanied by a significant 
reduction in mechanical properties of HA and HA/TCP ceramics, and subsequently restricts 
their applications where sufficient strength is needed. Our ceramic samples showed well 
expressed microporosity in the range of 100 nm up to 10 μm, the first formed due to the SiO2 
gel matrix, and the latter formed naturally by the manufacturing process during the heating 
(Fig. 4.11). Macroporosity is as well nicely presented, which appears to be of a great 
importance for the biodegradation of our ceramics. While the ceramic samples were extruded 
in the spaghetti form, macropores in mm range were formed between the spaghetti (Fig. 4.12). 
The existence of micro- and macropores on the other side, weakens the mechanical properties 
of these ceramics.  
 
Figure 4.12 : Scanning electron micrograph of 
spaghetti-shaped ceramic, which shows pores 
in macrorange, magnification x50   
 
 
Le Huec et al. (39) have demonstrated the 
influence of porosity on the compressive 
strength of the porous HA. They correlated the 
resulting compressive strength with both 
macroporosity and microporosity by a 
polynomal equation and indicated the 
possibility for designing a porous HA ceramic with optimized properties. It was reported by 
them that macropores have a greater influence upon the compressive strength than the 
micropores. At a given porosity, the compressive strength was found to decrease roughly 
linearly with macropore size as illustrated in Figure 4.13. The porosity-dependent strength 
Chapter 4. Manufacturing of calcium phosphate silica-based ceramics                                                                 59 
becomes insensitive to the porosity volume when the level of porosity reaches greater than 70 
vol. %. 
 
 
Figure 4.13: The compressive strength of HA ceramic of nearly identical porosity decreases 
linearly with increased macropore size (from Ref. 36) 
 
The influence of pore geometry on the compressive strength has currently been found to be 
important in producing porous HA or HA/TCP ceramics. The porous HA ceramic containing 
oblate pores is expected to have a lower strength than that with either ellipsoid or sphere 
pores, and the pores with spherical geometry exhibit better resistance to stress loading (39).  
The shrinkage can be calculated using the following formula: 
                                  
        Shrinkage % = 100 - (V1/Vo x 100)                         (13) 
 
where Vo is the volume of the samples before the heat treatment, and V1 is the volume after 
the heat treatment. The development of shrinkage/temperature dependence can be seen on 
Figure 4.14. From the starting temperature 200°C until 800°C no visible changes in the  
volume shrinkage of HA and BCP ceramics are observed. After this temperature both 
materials show an abrupt increase in their shrinkage; for HA ceramic it is from 7 % to 57 %, 
and for BCP ceramic is from 3,5 % to 50 %. Although biphasic calcium phosphate silica-
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based ceramic has shown lower porosity when sintering temperature increased, when 
comparing the shrinkage of both materials, we should note that HA and BCP ceramics behave 
in similar way. The small difference in shrinkage between HA and BCP ceramics at high 
temperatures can be neglected, since both display a linear increase upon sintering. 
Nevertheless, the higher shrinkage in HA ceramic in comparison with BCP ceramic can be 
explained with the different amounts of calcium phosphate powders in the starting materals. 
Since in HA ceramic there is less calcium phosphate powder and a higher portion of silica gel, 
the latter upon sintering shrinks, which reflects to the shrinkage of the whole material. In 
contrary, in BCP ceramic the silica portion is less (in both ceramics the molar ratio Si
4+
/Ca
2+ 
differs) and with sintering its shrinkage does not reflect so greately the shrinkage of the whole 
body. Krajewski et al. (40) had reported that in the temperature interval between 1200-
1250°C hydroxyapatite undergoes a sharp evolution and the shrinkage reaches its highest 
value – about 25% overall. Raynaud et al. (41) had explained the shrinkage phenomena as a 
presence of two domains in the shrinkage/temperature dependence. The first one they 
associated with calcination for temperatures up to 700°C, and the second is associated with 
sintering above that temperature, where densification mechanisms occur. Our resuls can also 
be interpreted by using the same explanation, since before 700°C no great changes in the 
shrinkage behaviour of HA and BCP ceramics occurred.      
 
 
Figure 4.14: Shrinkage-temperature dependence of HA and BCP ceramics 
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It has been demonstrated that the implantation of orthopaedic implants modifies the 
physiological mechanical stress pattern of the surrounding tissue and that the mechanical 
environment is directly related to the elastic property (stiffness) of the implanted materials. To 
minimize the mismatch in stiffness difference between the implant materials and hard tissue, 
one of alternatives is to make porous implants. The introduced porosity allows the stiffness of 
the implant materials to be adjustable; however, deteriorates the strength. Liu et al. (39) had 
reported an exponential decrease of elastic constant with porosity of HA ceramic, over the 
porosity ranges of 18-50 %. Human bones have elastic constants generally in the range of 10-
25 GPa, corresponding to the porous HA ceramic with a porosity of approximately 50 vol.%.      
The ceramic samples which were used as implants in the mini pigs animal model, have 
shown a very good porosity level – between 60 and 80 %, with three types of pores in macro-, 
micro-, and nanorange. On one side this fact is very promising for biodegradibility of the graft  
substitute material, but on the other side is a limitation for the usage of these ceramics in load-
bearing applications.  
 
 
 
4.5 Mechanical testing of calcium phosphate silica-based ceramics 
 
 
In weight bearing structures such as the human skeleton, each newly developed 
biomaterial needs to be mechanically tested to ensure its functionality and reliability. For 
metals, the test protocols are well known and standartized. For bioceramics, measurement of 
their multiaxial mechanical properties is more difficult, since their behaviour depends heavily 
on the microstructural defects associated with the manufacturing process. The mechanical 
properties of dense synthetic hydroxyapatite, as with all engineering ceramics, are highly 
dependent on the processing route, as a consequence of the effects of processing on the 
microstructure of the final product. This dependency results from mechanical sensitivity to 
parameters, such as variations in grain size, micropore size and micropore distribution.  
Conventional methods of mechanical characterization such as tensile, biaxial and 
impact testing are unsuitable when applied to porous materials due to the difficulties 
encountered in machining and gripping test pieces without causing pre-damage. Compression 
testing has been successfully used by a number of authors in the characterization of 
cancellous bone and has also been adopted in the testing of porous and dense hydroxyapatite. 
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However, in addition with the difficulties resulting from the inherent variations in porous 
samples, testing conditions should be carefully controlled. Comprehensive investigations into 
a number of key test-piese parameters, such as specimen shape, aspect ratio and size, have 
demonstrated that cylindrical specimens with an aspect ratio or 2:1 (length-diameter) should 
be standardized for compression testing of highly porous materials (26).     
The samples we used for mechanical testing were shaped as bars with rectangular (2,9 
x 1,5 x 0,8mm) form. After drying they were exposed to heat treatment in electrical furnace in 
air atmosphere for 2 hours at 200°C, 300°C, 400°C, 500°C and 600°C. The mechanical tests 
were performed on a Shimadzu AG-50kNG instrument under computer control in DOT 
Company (Rostock, Germany) with 1 N load cell. The compressive strength of the bars was 
determined using a centric load applied to a spring-suspended steel bearing block and test 
speed of 1mm/min, until catastrophic brittle failure occurred. Figure 4.15 represents the 
results from compressive strength measurements for hydroxyapatite silica-based ceramic.  
 
 
 
 
Figure 4.15: Temperature dependence of compressive strength for HA ceramic 
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It is prominent that almost no changes occur in mechanical strength with increasing the 
temperature from 200°C to 600°C. The highest strength is 3,5 MPa for samples heated at 
600°C, which does not differ very much from the strength of the samples heated at 200 °C – 
2.5 MPa. There is an explainable increase in compressive strength with increasing the 
temperature, but in the temperature interval between 200°C and 600°C this increase is almost 
negligible. The  strength difference of our samples is more obvious when they were exposed 
to temperatures up to 1200°C – in this case we have found out that the compressive strength 
has increased more than 10 times for samples exposed to 1200°C in comparison with samples 
heated at 300°C. Figure 4.16 shows the compressive strengths for BCP ceramics, on which 
the specimen heated at 1200°C has 51 MPa compressive strength, and the one heated at 
300°C has less than 5 MPa compressive strength. These results are impressive and seem to be 
very useful for further study, where mechanical strength would be a necessary requirement for 
load-bearing applications. There is one possible trouble to be worthy of, and this is the 
thermal decomposition of our  ceramic samples upon sintering, which was already discussed.  
The thermal behaviour of a biomaterial is as important for in vivo applications as the 
biodegradation and resorption. From material standpoint both HA and BCP ceramics have 
shown very promising mechanical properties, which can be successfully applied as load-
bearing materials. But in order to escape from undesired changes and transformations during 
heating (i.e. sintering) we do not recommend higher heat treatment for HA and BCP silica-
based ceramics than 1000°C (see also the explanations about the thermal decomposition in 
paragraph 4.3). 
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Figure 4.16: Temperature 
dependence of compressive 
strength for BCP ceramics 
heated between 300°C and 
1200°C (Spannung is strain 
in N/mm
2
 or MPa, Weg is 
distance in mm) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The mechanical tests obtained for BCP ceramics are very similar to those obtained for HA 
ceramic (Fig. 4.17). The escalating of temperature leads to an increasing of the mechanical 
strength, which at 600°C shows slightly higher value compared with HA ceramic heated at 
the same temperature (3,6 MPa for BCP and 3,5 MPa for HA cramics). This small difference 
can be neglected, but according to the molar ratio Si
4+
/Ca
2+
 of the starting materials, which in 
the case of BCP ceramic is lower, one can expect that the more the amount of calcium 
phosphates in the specimen, the higher the mechanical strength. Perhaps this difference can be 
overtaken due to the almost no changes in compressive strength of both ceramics up to 600°C, 
but when increasing the heating temperature, it could be possible to obtain higher values of 
the mechanical strength for BCP than for HA ceramic.           
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Figure 4.17: Temperature dependence of compressive strength for BCP ceramics  
 
 
In their work Akao et al. had mentioned that the compressive strength of sintered 
hydroxyapatite, synthezised by them is approximately 3 to 6 times as strong as that of cortical 
(compact) bone. It should be mentioned that the strength of compact bone depends both on 
degree of calcification and on fibre orientation. The hydroxapatite precipitated and used by 
these researchers had shown very good and even superior mechanical properties than cortical 
bone, dentine and enamel and as they have suggested it can be used as bone and tooth implant 
as well as for load-bearing applications (42). 
It must be noticed that the strength of samples which consist of biphasic calcium 
phosphate ceramic is the same as the strength of monophasic ceramic, where no particular 
changes in the structure of both ceramics up to 600 °C occur. The mean compressive strengths 
of our materials (heated only to 600 °C) are given in Table 4.2 in comparison with the 
strengths of enamel, dentin, compact bone, and cancellous bone (11). 
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Material Compressive strength 
(MPa) 
Tensile strength 
(MPa) 
Modulus of 
elasticity (GPa) 
HA ceramic 3,7 (our mat.)   
HA/TCP ceramic 3,45 (our mat.)   
Enamel 241(23); 384(11) 10,3(11) 82,4(11) 
Dentin 138(23); 295(11) 51,7(11) 18,2(11) 
Compact bone 167(23);163,8(11) 88,9-113,8(11) 3,88-11,7(11) 
Cancellous bone 1,86   
 
Table 4.2: Compressive and tensile strength, and modulus of elasticity of various hard tissues  
(Data for HA and HA/TCP ceramics are elevated after heating at 600 °C) 
 
As many investigators had pointed out (38) the mechanical properties of calcium 
phosphate ceramics improve rapidly in vivo due to bone ingrowth in macropores and 
reprecipitation of biological apatites in micropores. As it will be shown later when presenting 
the results from our in vivo experiments, the defect created in the right proximal tibia of 
Goettinger mini pigs was healed very well, and no complications regarding absence of 
mechanical strength were observed.  From all of the tested animals (6 in number), only one 
has gotten a fracture, which could be related to different reasons, e.g. surgical conditions, 
acceptance of the implant, animal health status, etc. In our research we did not measure the 
compressive strength after the implantation, but many other authors have reported an increase 
in compressive strength for bone derived porous HA from 4 to 20 M Pa after 3 months in vivo 
(43). The same authors had stated 300% increase of the compressive strength within 5 weeks, 
despite complete osseointegration at this time. These results indicate, that with time, the 
mechanical behaviour of osseointegrated implants many become independent of the initial 
implant strength as a result of reinforcement by bone ingrowth. Therefore, to provide a good 
compromise between satisfactory bone ingrowth and acceptable mechanical resistance, many 
animal and clinical studies recommended calcium phosphate ceramics with approximately 50 
% macroporosity. Our ceramics materials have a porosity between 60 % and 80 % and 
relatively low compressive strength, but during the implantation period the implants have 
shown a good biodegradibility and ability to promote bone substitution. We do not find it as a 
disadvantage that our ceramics do not posses a high mechanical resistance. Notwithstanding, 
the achievement of high porosity in combination with sufficient mechanical resistance should 
be one of the next priorities to investigate in our laboratories.   
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CHAPTER FIVE 
 
In vitro study. Results and discussion 
 
 
The evaluation of cell-material interactions is of main importance when developing 
new materials for biomedical applications. A biocompatibility study should be done in order 
to prove the biodegradibility of certain designed biomaterial, and its bone conducting 
behaviour. This chapter will present an osteoblast cell culture study, which have been used in 
order to determine the potential of calcium phosphate silica-based ceramics to elicit specific 
responses to bone cells in vitro.  
 
 
 
  5.1 Variety of in vitro study tests and tissue responses to a foreign body 
 
 
Formation of a biologically equivalent apatitic surface, a common characteristic of 
bioactive materials, can be reproduced in vitro by immersion using a simulated physiologic 
solution that mimics the typical ion concentrations in body fluids, or cell containing media 
(44). Such experiments have shown that the materials with high solubility also readily induce 
the precipitation of a biologically equivalent apatite on their surface. Using this in vitro 
immersion methodology, considerable evidence has been obtained revealing the mechanisms 
of surface reactions. The reactions include dissolution, precipitation and ion exchange 
accompanied by absorption and incorporation of biological molecules. 
Bone collagen is considered to be intimately involved in the nucleation of bone 
mineral, a hypothesis supported by electron microscope studies of developing bone in which a 
periodic deposition of new bone crystals is seen in relation to collagen fibrils (16). Since there 
is a broad range of materials available and only a very small percentage have been used in 
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biological environments, there has been a continual need for quick methods that can be used 
in vitro. These can be divided into two general classes: 
 Tissue culture methods 
 Blood contact methods - for blood contact applications in cardiovascular system 
Within each of these classes there is a wide variety of tests and variations of test methods. 
Some variations are traditional for particular applications, while others are the practice of a 
particular laboratory. 
Tissue culture refers collectively to the practice of maintaining portions of living tissue in 
a viable state in vitro. There are three generic methods: 
1. Cell culture: The growth of initially natural matrix-free, disassociated cells. Cells may be 
grown in solution, or on agar, or other media substrates. Exposure to biomaterials may be 
through direct contact with bulk materials, diffusional contact through agar (or other gel) 
intermediate layer, or by inclusion of extracts or elutants from materials in the culture 
media. 
2. Tissue culture: The growth of portions of intact tissue without prior cellular dissociation. 
Exposure to biomaterials is similar to that for true cell culture. 
3. Organ culture: The growth of intact organs in vitro. This may vary from the use of fetal 
bone explants which can survive without external support systems to the use of whole, 
adult, perfused organs such as the kidney or heart. A variety of exposures to biomaterials 
is possible. 
Cell types may vary in activity and properties between species, and, in species, between 
individuals, and within a specific cell line, between generations. Tissue culture techniques as 
a group may be used to study the cell survival (toxicity, membrane integrity), cell 
reproduction (growth inhibition), metabolic activity (energetics, synthesis, catabolism), 
effective activity (inhibition of locomotion, chemotaxis and phagocytosis, alteration of 
cellular shape and size) and cell damage (chromosomal aberration, mutagenicity and 
carcinogenicity) (45).  
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5.2 Cell isolation and culture  
 
 
A cell culture system has been used in collaboration with our colleagues from 
biochemistry department to study the biocompatibility of tricalcium phosphate silica-based 
ceramic and hydroxyapatite silica-based ceramics with different silica/calcium ratios. 
Osteoblasts are cells that support the formation, secretion and mineralization of the 
extracellular matrix of the bone tissue (46). Therefore, some of the fundamental principles 
like cytoxicity, cell proliferation and differentiation, cell viability can be tested in vitro using 
osteoblast cultures. Many researchers have used lineage cells, because of their easier culture 
behaviour (46). According to a method used by Gerber et al. (47) for the in vitro test we have 
used osteoblasts, obtained from the hips of patients with primary coxarthrose. The cells 
isolation was done by the use of enzymatic treatment with dispase and collagenase of the 
bony specimens. The ceramic materials were seeded in the culture medium for 10 days. After 
the cultivation with osteoblasts the ceramic samples were fixed with 4% glutaraldehyde 
solution and were prepared for examination with raster electron microscopy.  
  
 
 
5.3 Results and discussion 
 
 
Figures 5.1 a-d showed the scanning electron micrographs of hydroxyapatite samples 
with different Si/Ca molar ratio: from 2.9 up to 6.5. On the surface of each material attached 
cells with round form can be seen and they seem to be active. Figure 5.2 represents the 
surface of hydroxyapatite ceramic without cell culture. The roughness of the ceramic is 
obvious, where isolated smooth islands of silica gel are visible. These areas have different 
thickness and small cracks, possibly due to heating of the samples prior to the preparation 
technique. The cells attach preferably to the ceramic surface with less (in thickness) silica gel.  
Therefore, the adhesion of cells which lie down directly on the ceramic surface is greater than 
the one on smooth surface, which consists mainly of silica gel. Figures 5.3 a-b are SEM 
photos of tricalcium phosphate silica-based ceramic which has been cultured for 10 days. 
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Here the activity of cells, which adhered to the ceramic surface is higher and they produced 
collagenous extracellular matrix, which spreads over the surface.   
 
    
 a)                        b) 
 
 
    
 c)            d) 
 
 
Figure 5.1 : In vitro testing of hydroxyapatite silica-based ceramics with different Si/Ca 
molar ratios, where a) is  2.9 ,x2000; b) is 3.6, x2000 ; c) is 4.5, x3000,  and d) is 6.5, x2000 
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Figure 5.2 : Scanning electron micrograph of 
hydroxyapatite  ceramic surface, 
magnification x3000 
 
 
The surface roughness of materials has long 
been recognised as an important factor in the 
generation of cell and tissue responses to 
implants. Behling and Spector have reported 
an increased cell adhesion to rougher than to 
smoother surfaces (48). Our ceramics materials 
have shown to have surfaces which can be determined as mixed, rather than only smooth or 
rough because on one side there are smooth regions, which are not distributed uniquely over 
the whole surface area, and rough domains which are responsible for the cell attachment and 
further mineralization (Fig. 5.2). Similar results were confirmed by Gomi et al. (49) where 
statistical analysis had shown greater number of attached marrow cells on the rougher 
hydroxyapatite surface than on the smoother hydroxyapatite surface.  
 
 a)               b) 
       
 
Figure 5.3: In vitro testing of calcium phosphate silica-based ceramic. Note the formation of 
collagenous extracellular matrix on (a), x1000; (b) is a higher maginification of (a), x2000 
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High-resolution transmission electron microscopy has revealed the two stages of 
physicochemical events occurring after the implantation of biphasic calcium phosphate 
ceramics, i.e. crystal dissolution and the precipitation of biological apatite characteristic of 
bone-bonding capacity (50). These dissolution/precipitation processes are not caused directly 
by cells but by fluid, even though they may be influenced by absorption of cell-derived 
proteins onto the ceramic surface. Yet it is reasonable to suppose that, apart from these 
physicochemical events, cellular events also occur in vivo circumstances in which numerous 
cells of various kinds are present.   
The osteoclastic degradation of ceramic surfaces (i.e. formation of resorption lacunae) 
results from the total effects of ceramic properties (and especially solubility) and the action of 
osteoclasts on ceramics (resorption activity). It would appear that more soluble a calcium 
phosphate ceramic is, the more extensively it is resorbed by osteoclasts, which is in fact the 
case when ceramics solubility is within certain limits. The chemical properties of ceramics 
may influence osteoclast resoprtion activity. For example, a very soluble ceramic might not be 
suitable for active resorption by osteoclasts, since a lagre number of released calcium ions 
could inhibit osteoclast activity.  
The authors (51) have compared 4 types of calcium phosphate ceramics: pure HA, 
pure TCP, and BCP ceramics with two different molar ratios – one with 25/75 and another 
with 75/25 HA/TCP molar ratio. Their findings suggest better osteoclast resorption on pure 
TCP surface and on BCP ceramic with lower HA/TCP ratio. It is well known that the 
solubility of pure TCP is higher than that of BCP and HA ceramics, thus the osteoclast 
resorption is well expressed on the surfaces of these ceramics. However, an increased ceramic 
solubility is not always related to extensive osteoclast resorption, as mentioned before.   
Osteoclast resorption activity may be influenced by osteoblast activity or bone matrix proteins 
produced by osteoblasts. Using a two-stage culture system, de Bruijn et al. (52) showed that 
osteoclastic resorption of TCP occurred under an extracellular matrix layer formed by 
osteoblasts. They concluded that the extracellular matrix was able to increase the resorption 
activity of the osteoclast.  
The physicochemical events occurring at the interface between calcium phosphate 
materials are thought to be responsible for chemical bonding of bioactive implants with bone.  
LeGeros et al. (53) summarized these events as: 
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1) Decrease in the pH in the environment of the calcium phosphate ceramics causing partial 
dissolution of the ceramic monocrystal;  
2) increase in the concentration of calcium and phosphate ions in the microenvironment;  
3) formation of  CO
3-
 apatite crystals (by precipitation, by transformation from one Ca-P 
phase to another, or by seeded growth) incorporationg ions  (e.g. Mg 
2+
, CO 
3-
) from the 
biological fluids;  
4) association of the CO
3-
  apatite  microcrystals with an organic matrix, and  
5) incorporation of these microcrystals with the collagenous matrix during the formation of 
new bone at the interface.  
In the present in vitro tests all calcium phosphate ceramic materials supported the 
expression of cell growth on their surfaces. This may actually suggest that these materials can 
enhance osteogenesis. As a result, these biomaterials can be considered excellent bone 
substitute materials. In order to understand this, a very good correlation between the in vitro 
data with the in vivo phenomena should be performed. Therefore, we have decided to 
continue with the animal tests in order to prove the ability of our ceramics to degrade  in vivo 
and to act as a scafold for bone formation. 
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CHAPTER SIX 
 
In vivo examinations of calcium phosphate silica-based 
ceramics. Results and discussion 
 
 
With the current state of affairs in biomaterials science, only patients with relatively 
small bone defects can be effectively treated with reconstructive bone surgery. With larger 
bone defects it is always necessary to use either autologous (i.e. from the own patient) or 
donor bone. There are no suitable treatments available for major load bearing bone defects. 
This is because bone is a living, dynamic tissue with specific biological and mechanical 
properties that are not found in artificial materials. Bone uniquely combines elasticity and 
stiffness and is always capable of adapting itself to changing circumstances. This adaptability 
is primarily due to the combined action of bone forming and bone resorbing cells.  
In this chapter we will discuss the in vivo behaviour of the produced in our laboratory ceramic 
materials (hydroxyapatite calcium phosphate silica-based ceramic and biphysic calcium 
phosphate silica-based ceramic), and will try to give relevant explanations about mechanisms 
of bone mineralization and formation with the help of histological, polarized and electron 
microscopy, and X-ray diffraction observations. 
 
 
 
6.1 Implantation procedures 
 
 
In order to observe the in vivo behaviour of the designed in our labortory mono-and 
biphasic calcium phosphate silica-based ceramics, we used Goettinger mini pigs as an animal 
model. The implantation period was divided to 5 weeks (short-term test) and eight months 
(long-term test). The surgical procedure was made as follows: a total of 16, 1-year old, adult 
Goettinger mini pigs weighing between 25 and 30 kg were used for the study. In four pigs the 
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biphasic ceramic was introduced in their lower left jaw and these animals were left for 5 
weeks, after which period they were sacrificed and the results were analyzed with electron 
microscopy and by histological methods. In the rest 12 pigs, the mono- and biphasic ceramics 
were separately introduced in the lower left jaw, where a defect of 5 cm
3
 was created by 
removing the whole cortical bone (6 animals received monophasic ceramic and 6 animals 
received biphasic ceramic). Additionally a second operation in 8 of these pigs was made, in 
which another defect was created in the right proximal tibia of each pig and the monophasic 
(2 animals) and the biphasic (6 animals) ceramic materials were introduced (Table 6.1). All 
ceramic samples were sterilized before the operations in autoclave at 180°C. After the 
surgical procedure the animals were left in their natural surrounding and were watched daily 
for any complications. Eight months after the surgery the 12 pigs were sacrificed. 
Histological, X-ray and microscopical studies were accomplished. Four pigs were used as a 
control group with empty defect, in which no material was introduced. 
 
 
Test period Number of  tested 
animals 
Implanted material Implantation site 
Short term-five weeks Total 6 animals BCP Lower left jaw 
Long-term- eight months Total 12 animals BCP - 6 animals 
HA -  6 animals 
Lower left jaw 
  BCP - 6 animals 
HA - 2 animals 
Right proximal 
tibia 
Short term-control group  Total 4 animals Empty defect Lower left jaw 
 
 
Table 6.1: Distribution of the test animals related to the implantation periods  
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6.2  Results from short-term in vivo study (five weeks)  
 
 
The short-term in vivo test is important for observation of an early mineralization and 
bone formation and the mechanisms for occurring of the latter. As it was already mentioned in 
the beginning of this chapter, for the purpose of this examination period a total number of six 
mini pigs were used into which only biphasic calcium phosphate silica-based ceramic samples 
were implanted. The implantation site was the left lower jaw (mandible), where the spaghetti 
look-like samples were introduced (see also Fig.4.3). These defects had an overcritical size (5 
cm
3
), which means that usually no healing could occur by the natural remodelling and 
deposition of bone. In the mandible the defects were created by removing the cortical bone 
and thus leaving two openings from the inner and outer part of the bone. Figures 6.1 to 6.5 
represent the operation procedure, performed by surgeons in the Department for Oral and 
Maxillofacial Surgery at Rostock University.    
  
Figure 6.1: Creation of the defect in the 
lower left jaw of Goettinger mini pig after 
drilling a holes in the inner and outer part 
of the manible 
 
 
 
 
 
Figure 6.2: View of the removed piece of bone 
from the mandible with an overcritical size – 5 
cm
3
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Figure 6.3: Control group defect after 5 weeks. 
Note the formation of the callus, typical when no 
healing occurs due to bigger defect size    
 
 
 
 
 
Figure 6.4: Scanning electron 
micrograph after 5 weeks, showing the 
encalpuslation of the empty defect by a 
fibrous tissue, scale bar 10 μm  
 
 
By raster electron microscope one could 
observe the encapsulation around the 
empty defect by fibrous tissue (Fig. 6.4). 
In the photograph image of the control 
defect it is possible to see that the defect 
in five weeks is still not closed due to its 
overcritical size (Fig. 6.3). This could mean that the healing of the defect is continuing.         
 
 
Figure 6.5: Filling the defect with BCP 
ceramic and waiting for the material to be 
absorbed by the blood proteins, before 
closing the defect    
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Before closing the defect, the surgeones had waited until the bioceramic has absorbed the 
blood proteins, as a necessary precaution against further complications. Figure 6.5 shows the 
process of filling the defect with the bioceramic particles, which after absorbing the blood 
proteins due to their high porosity became red. 
 
Figure 6.6: Defect with BCP ceramic 
after 5 weeks. Note the presence of newly 
formed bone on the left and right site of 
the defect and still not resorped material 
in the middle. The blue rod indicates the 
place where thin histological sections 
were cut from defect     
 
 
 
Figure 6.7:  X-ray diffraction pattern of 
the bioceramic before (upper part) and 
after5 weeks of implantation (lower part). 
Note the intensity of the correspoding 
peaks for TCP from the edge of the defect, 
which is lower compared with TCP peaks 
in the bioceramic. This is a result from 
fast ceramic resorption within five weeks   
 
 
 
 
 
 
 
 
Figure 6.6 presents the defect and the bioceramic, which was removed after five weeks. From 
the edge of the defect (blue rod on Fig. 6.6) thin sections were cut, which were afterwards 
used for the histological studies and for microscopical observations. An X-ray powder 
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diffraction taken from the implanted material after 5 weeks, shows almost 50 % decrease for 
TCP corresponding peaks, in comparison with their intensity from the bioceramic X-ray  
powder diffraction spectra (Fig. 6.7). The decrease of TCP peak is an effect of dissolution and 
it occured independently on the tissue ingrowth as can be seen on Fig. 6.7 (lower part), 
because there is very slight difference between the peak intensity taken fom the edge, where 
new tissue growth is faster and the one taken from the middle of the defect.   
The histoligical cuts from the fifth week, registered the first results from the 
degradation of biphasic calcium phosphate ceramic and formation of new bone tissue. Figure 
6.8 shows the resorption of our ceramic by employing Toluidine blue staining, which is a 
basic staining usually used in histological tests. The pieces of ceramic (A) are surrouned by 
bone (coloured in blue, B), which is in a very intimate contact with the material. The surface 
of the ceramic has a mouth eaten appearance, where the osteoclast activity is very high (C). 
Due to this osteoclast activity the ceramic material is undergoing resorption and consequent 
degradation. Figures 6.10 and 6.15 support as well the evidence for high osteoclast activity. 
Parallely to this, another change in materials´s state had occurred and this is its degradation 
(D), which is caused by material composition, and by the biological fluids which surround the 
bioceramic.  
 
 
 
Figure 6.8: Histological evaluation of the 5 weeks defect (Toluidine blue stain). The ceramic 
material (A) shows a mouth eaten appearance (C) and it is surrounded by bone (B)  
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All our findings from the histological test can be confirmed by the results obtained with 
polarisation microscopy. In this examination, an embedded in glutaraldehid section from the 
edge of the defect (Fig. 6.9) is exposed to visible light under polarisation microscope, where 
according to light double breakdown, the different objects become coloured in dissimlar way. 
Figure 6.9 gives a typical view of the defect after five weeks, showing the ceramic piece 
surrounded by newly formed bone in the macropores, as well the very close contact between 
the bone and bioceramic. This is an evidence for direct bone apposition on the ceramic 
surface like nucleation (see the small blue dots over the ceramic material in Fig. 6.9).  
   
           
 
          
 
 
 
 
 
 
 
 
 
 
 
Figure 6.9:  Polarisation microscopy image of the bioceramic (in dark) showing the new 
bone formation directly on the ceramic surface (the small blue dots) and in the macropores 
  
Figures 6.10 and 6.11 are demineralized histological cuts stained with Hematoxylin Eosin 
staining. With the help of these images we can clearly see the process of material`s resorption. 
On Figure 6.10 the ceramic material (A) has a round shape, but in some parts became concave 
which is due to the osteoclasts activity (Oc). There is a very close contact between the 
ceramic and the bone matrix (BM), which after mineralization is turned into mature bone (B). 
The osteoblasts are also to be found (Fig.6.11, Ob), which cover the concave surface and are 
responsible for deposition of new bone.   
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Figure 6.10:  Demineralized histolgical cut after 5 weeks, where A is the bioceramic, which is 
undergoing resorption by osteoclasts (Oc) with concequent formation of bone matrix (BM), 
which after mineralization is turning to matured bone (B), (Hematoxylin Eosin staining)  
   
 
         
Figure 6.11: Osteoblasts (Ob) lining the concave surface of bioceramic (A) (HE staining)  
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          The process of new bone formation in the macropores can be observed by staining the 
histological cuts with Goldner stain, which coloures the mineral component in dark green, and 
the collagen fibres in yellowish. Figure 6.12 is a cross-section of the surrounded by collagen 
fibres bioceramic (in green), and the trabecular structure of the remodelled bone. At this stage 
the orientation of collagen fibres is low, therefore they can be seen running in different 
directions, but in very close vicinity of the bioceramic. 
 
   
 
 
Figure 6.12:  Lamellar bone structure around the bioceramic (in green) as seen with Goldner 
stain. The collagen fibres (coloured in yellow) run in different directions and around the 
bioceramic 
 
 
An enlarged fragment from Fig. 6.12 shows the mineralization of these collagen fibres (Fig. 
6.13, the small green dots), which is connected with crystals formation (hydroxyapatite) and 
further maturation of these crystals to give rise to new bone. The collagen mineralization 
occurred as a front in direction from the edge of the defect to the middle. This is another proof 
that new bone tissue forms first at the edges of the defect and continue further throughout the 
whole defect.    
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Figure 6.13: Enlarged view from Fig. 6.1. showing the collagen mineralization  (GS)  
 
 
Figure 6.14: Polarized light 
microscopy image indicating the 
process of material resorption and 
mouth eaten appearance left after 
osteoclast activity.  
 
 
 
The process of material`s resorption 
and degradation is accomplished by 
the activity of osteoclasts. These cells “digest” the ceramic material (and even the newly 
formed bone) by leaving a holes on material surface (Fig. 6.14). The multinucleated osteoclast 
cells invaded the material and as a consequense its round shape is destroyed (Fig. 6.15). At 
the same time, another object of the osteoclast activity is the new bone, which undergoes 
remodelling by the same manner as the bioceramic (Fig. 6.16). Basically, there is no 
difference in the osteoclast activity of the bioceramic and of the newly grown bone.     
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Figure 6.15: Osteoclasts activivty (Oc) creates  holes on materials`s surface (A), (HE 
staining) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.16: Newly formed bone (B), which surrounds the ceramic (A) undergoes 
remodelling by osteoclasts (Oc), (HE staining) 
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Figure 6.17: Cross-section from the 
middle part of five weeks old defect, 
showing bioceramic (B) and tissue (A), 
SEM, scale bar 50 μm. At higher 
magnification collagen fibres 
undergoing mineralization filled up the 
micropores of the ceramic, scale bar 4 
μm  
 
 
 
 
 
Figure 6.17 is a cross-section from the middle part of five weeks old defect, where the speed 
bone formation is low. These collagen fibres have permeated in the micropores of our 
bioceramic and are undergoing mineralization, which led to the formation of the biological 
hydroxyapatite crystals. Thus, the osteoclastic resorption of our material is very well 
expressed. The duration of these experiments is short, so that we cannot show whether an 
abundant new bone has been formed. It is well apparent that in five weeks the ceramic 
degradation has started, which proves to be with high surface activity. Therefore, short-term 
study is important for giving us information about: 
 
1. Ceramic degradation and the way it occured 
2. New bone formation as a sequence of collagen mineralization 
3. Presence of two types of bone formation 
4. Correlation between material degradation and bone remodelling  
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6.3 Results from long-term in vivo study (eight months)  
 
 
In the previous paragraph it was mentioned that the degradation of our ceramic 
materials in vivo is a cell-mediated process, i.e. it is governed by the osteoclastic activity.  The 
purpose of the long-term examination period is to show whether there is a healing of the 
artificially created bone defects (in the mandible and tibia), and whether the bioceramic is 
degrated and substituted by newly formed bone. Briefly, the surgical procedure was 
performed in the same way as the short- term period, with the only difference, that in this 
study in six of the animlas in their right prixmal tibia mono-  and biphasic calcium phosphate 
silica-based ceramics were introduced additionally. For the eight months tests, a total of 12 
mini pigs were used, of which 6 received BCP ceramic in the mandible, and 6 had received 
HA ceramic in the mandible. In eight of these pigs an additional defect in the right proximal 
tibia was created, where two of the operated pigs had received HA ceramic in the shin bone, 
and other six pigs had received BCP ceramic in the shin bone. The duration of this testing 
period was eight months, after which all the pigs were killed and  thin sections from the 
implantation sites were cut  in order to be studied with histological and microscopical 
methods. Figures 6.18 illustrate the mandible after 8 months, presenting very well clinically 
healed defect. The site which had received the bioceramic (marked by arrows) is thicker than 
the site without defect (Fig.6.18a), but there is no visible sign of the medical intervention (Fig. 
6.18b).     
 
                          
a) b) 
Figure 6.18: Image of the mandible defect in 8 months: a) underneath view showing that 
the left site with defect is thicker, but clinically healed; b) direct view from defect place 
with no visible marks on the bone  
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Figure 6.19: Roentgenographical image 
of the mandible in 8 months: the upper 
part is the right part of bone where no 
defect was created, and the lower is the 
left bone part, with two titanium rods, 
locating the place of the defect. 
 
 
 
 
On Figure 6.19 the defect in the 
mandible is shown roentgenographically 
after the animal had been killed. The two 
white titanium rods on the lower jaw are locating the position of the defect. When compared 
with the roentgenographical image of the same animal taken postoperatively (Fig.6.20), one 
could think that in 8 months the material can be still found in the defect and that its 
degradation did not take place, which is not true. The histological cuts (Fig. 6.21, 6.23) show 
clearly, that the ceramic is fully resorpted. 
  
 
Figure 6.20: Roentgenographical image 
of the mandible taken postoperatively. 
Two titanium  rods indicate the place of 
defect, filled with BCP ceramic 
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Figure 6.21: Histological cut from the 
mandible 8 months after the operation, 
showing a completely resorpted 
bioceramic and clinically healed defect 
(Toluidine blue staining)   
 
 
The histological results confirmed that in 
eight months the bioceramic was fully 
resorpted and at the place of medical 
intervention a new trabecular bone was started to be formed. From Figure 6.21 one could see 
that the stucture of the newly formed bone is cancellous which is different from the old 
cortical bone. The defect is consisting mainly of this cancellous bone, while the old bone is 
involved in the remodelling process.     
 
Figure 6.22:  Defect in the mandible in 8 
months, presenting the worst case from all 
histological cuts of all tested animals, 
(Toluidine blue staining) 
 
 
The process of  material degradation and 
resorption is not equally expressed in all of 
the operated animals. As an evidence we 
show another histological cut, which 
contain more ceramic material and its presenting the worst case of this study. (Fig. 6.22). This 
result only confirms that the acceptance of the material and its subsequent degradation is an 
individual process, which can vary between the testing animals. But it also could be due to 
manufacturing problems, where instead of “spaghetti”species we had gotten clusters, which 
degradation is slower for absence of macropores. In some animals, the histological cuts 
present less material (Fig. 6.23), which undergoes degradation and it is involved in the bone 
formation. Some statistic has been made to compare the results after 8 months, between HA 
and BCP ceramics implanted in the mandible. According to it, HA ceramic has been found to 
remain only 0.8 vol.% in the histological tests, while BCP ceramic is 3.4 vol.%.    
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Figure 6.23: An 8 months defect in the 
mandible with small leftovers from the 
bioceramic, which are involved in the 
remodelling process (Toluidine blue 
staining)    
 
 
 
 
 
 
                
               b) 
 
a) 
 
Figure 6.24: Roentgenographical image from the right tibia filled with the bioceramic (the 
top part of image a) taken after the operation; b) in 8 months the defect seems to be the same 
as after the operation. Note that the presence of some material is actually the trabecular 
bone, which is formed after the ceramic is being resorpted 
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When the ceramic material was implanted in the tibia no requirements regarding the 
mechanical stability were completed. The surgeones even did not put an external fixations, 
which is an usual procedure in long bones surgery. It has been shown in Chapter 4 that the 
mechanical strength of our ceramic heated to 600°C remains almost the same, and has a 
values between 2,5 and 3,7 MPa, which is not sufficient for load-bearing applications. 
Although,  the results obtained from the tibia confirmed the possibility of using our ceramic 
samples even in load-bearing sites with no preliminary fixations of the opeated place. Figure 
6.24 present the roentgenograpical images of the tibia defect immediately after the operation 
(Fig. 6.24a) and in eight months (Fig. 6.24b). Here again we see a remained ceramic after 8 
months, which leads to the misunderstanding that this ceramic has not been resorpted. In fact, 
the looking like-material appearance in Fig. 6.24b is the spongy bone, formed as a result of 
ceramic degradation.   
 
Figure 6.25: Histological cut from the 
tibia defect in 8 months. Some small 
remainings from the ceramic are to be seen 
(Toluidine blue staining)  
 
 
 
 
 
 
Figure 6.25 shows a nice result from tibia defect, where the bioceramic is fully resorpted and 
involved in the bone formation. Note that the thickness of cortical bone in the tibia is less than 
the thickness of cortical bone in the jaw bone. This on one hand can be a reason for faster 
remodelling and formation, but on the other hand the posibility for complications in tibia is 
higher compared to the mandible. In Figure 6.25 the newly formed bone has almost the same 
thickness as the original host bone, which is an evidence for good material degradation and 
nondisturbed bone formation. In the practice, implantations in the long bones are followed by 
external fixations to prevent occuring of fractures. Such an external fixations had not been 
done in the tibia implantations, thus, some of tested animals had gotten fractures (Fig. 6.26). 
As a result deformation of tibia occurred, which was related to complete degradation of our 
ceramic material as shwon on Figure 6.26. The fracture has caused on other site mechanical 
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disorder, which forced the process of bone remodelling and repairing with the faster 
resorption of our ceramic.         
Figure 6.26:  Tibia defect in 8 months 
with fracture. Note the changed shape of 
the bone and the absence of bioceramic, 
which was resorpted faster in order to 
support the mechanical load (Toluidine 
blue stainig) 
 
 
 
 
 
 
In the tibia defect like in the mandible, in some cases there are evidences for higher presence 
of the ceramic graft bone material in the defect (Fig. 6.27). This should not be considered as a 
bad result, because in all these cases, a spongy bone is found around the bioceramic, showing 
the continuity of material resorption and bone formation.     
 
Figure 6.27: Tibia defect after 8 
months presenting the worst case of 
material degradation. The presence of 
spongy bone around the ceramic 
particles (in black) is a result for 
undergoing resorption and remodelling 
(Toluidine blue staining) 
 
 
 
 
If  we compare how the process of bone healing and material degradation has been developed 
throughout the duration of long-term experiment we will find the following picture. In five 
weeks the bioceramic (Fig. 6.28a – BC) is present in the overcritical in size defect, coloured 
with yellowish green in the Goldner staining specimen. This is the organic part (collagen 
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fibres) of the newly formed bone. In the so created defect, due to its big size the activity of 
bone remodelling and bone formation processes is very high. The old host bone (OB), which 
is coloured in dark green is undergoing resorption and is slowly removed by the new bone 
(coloured in lighter green, NB). Thus, its role in supporting the mechanical stabiliy of the 
bone is overtaken by the new bone, which is forming at the periost in order to stabilize the 
mechanical function of mandible. The newly created bone at the periost, as well as in the 
whole defect, has a different structure from the host bone. As stated previously the new bone 
formation cannot be completed in five weeks, therefore in the beginning of our study we  
could find this structure difference. In parallel, the bioceramic macropores are permeated with 
collagen fibres, which differentiation guides the process of new bone formation. What is more 
important is the development of this bone formation within time, so that in eight months the 
defect in mandible has a disimilar appearance. Figure 6.28b proved, that after 8 months the 
ceramic graft material is resorpted and the precense of old bone is decreased, because of the  
undergoing remodelling. The defect is filled with trabecular bone, which is the result from the 
destroyed mechanical stability.  
 
 
      
a) b) 
 
Figure 6.28: Evolution of the new bone formationi in 5 weeks on a), where there is a very 
clear difference between the new (NB) and old bone (OB), (Goldner staining); b) shows the 
completely healed defect, which is mainly consisting of the newly formed bone (NB), while the 
old bone (OB) is involved in remodelling, (Toluidine blue staining) 
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6.4 Discussion of the results from in vivo study 
 
 
The mineralization and deposition of the newly formed bone occures in the vicinity of 
the ceramic material, which is a very good proof that the ceramic is involved in the 
degradation-mineralization-bone formation processes. On Figure 6.15 one can notice the 
surrounded by the multinucleated osteoclasts (Oc) biomaterial (A), which are “digesting ” it 
by formation of bone matrix around it (Fig. 6.10, 6.12). As a result of the osteoclast activity, 
the ceramic became degraded into Ca and P ions, which are necessary for the deposition and 
mineralization of the bone matrix. The osteoblasts are lining on the concave material surface 
(Fig. 6.11), and due to the enzyme alkaline phosphatase the mineralization is attended. The  
formation of a seam (osteoid) around the bioceramic as shown in Fig. 6.10, is intimately 
related with the formation of the new bone, as it is consisting of collagen fibrils and fibres, 
which will mineralize to give the mineral component of the new bone matrix (Fig. 6.12). The 
relative speed of formation and mineralization of the osteoid determines its width. Its believed 
that if the supply with Ca and P ions is enough for the process of bone matrix (or osteoid) 
deposition, then its mineralization will be faster. In a naturally bone deposition and 
remodelling process, the suppy with Ca and P ions comes from the blood proteins, and in the 
case of  foreign material which is inserted in the bone defect, Ca and P ions can be supplied as 
a result of materials dissolution. Thus, we believe, that according to the nice results which 
were shown from the histological study, in 5 weeks mineralization of new bone matrix occurs 
relatively fast, which is a proof for degradation of the implanted ceramic, for high activity of 
osteoclasts and osteoblasts, which “work” is not disturbed by the presense of calcium 
phosphate silica-based ceramic.                   
The resorption activity of osteoclasts is considered with the presence of island-like or 
track-like resorption lacunae on the surfaces of ceramic materials as reported by Yamada et 
al. (51). Depending on the ceramic surface properties and solubility, these resorption lacunae 
(or mouth eaten appearance on the ceramic surface) cannot be observed on each calcium 
phosphate ceramic surfaces. As it is very difficult to synthezise stoichiometric hydroxyapatite, 
CaO are usually found in commercial products. As the CaO impurities are very hydrosoluble, 
they may induce the formation of similar lacunae. In fact, those lacunae as shown by 
Soueidan et al. (54), are not due to cellular activity, but only to dissolution of CaO impurities. 
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Enlarged image (Fig. 6.15) gives better view from the activity of osteoclasts, which due to the 
secreted collagenase enzyme, are able to degrade the ceramic by forming a cave-look like 
appearance on its surface. Paralelly with the resorption of the bioceramic, there is also 
resorption of the host bone by osteoclasts (Fig. 6.16). We believe, that this result is very good, 
because it shows that the osteoclasts practically do not “make” any difference between the 
host bone and the ceramic material, and the resorption of both happen in the same way. In 
other words, the process of natural  bone resorption and deposition is not affected by the 
presence of our implanted ceramic. However, from a material standpoint, we believe that 
characteristics, such as crystal structure, packing between the crystals, determine the 
resorptive ability of the osteoclasts to resorb HA and BCP silica-based ceramics.   
According to our findings we can state, that the bone formation occurs in two ways: 
one is direct bone formation on the ceramic surface (Fig. 6.8, 6.9) and bone formation in the 
macropores of the biomaterial (Fig. 6.12, 6.13, 6.17). These results had proven once again  
that, our ceramic materials are able to promote both types of bone formation, which up to now 
has not been reported by anybody else. Tracy et al. (55) have reported that, the interface 
between hydroxyapatite cylindrical plugs implanted into rat femurs and bone showed a very 
intimate attachment of the bone to the hydroxyapatite implant, with no intervening tissue. 
After indicating the crystal type of bone close to ceramic interface, was posible to show that it 
was of the same size and shape as in the normal bone.  
In Chapter 2 we have discussed the structure of bone, bone formation and bone 
remodelling processes. It was stated, that the bone as dynamic living tissue undergoes 
remodelling throughout life, which results in the continual formation of interfaces between 
new bone and older bone tissue. This bony interface is represented by a distinct histologic 
structure called the cement line and which is a mineralized, collagen-free matrix 
approximately 0.5 μm thick. While bone is known to interface with itself by the mechanism 
of the above mentioned cement line formation, it would follow that bone will interface with 
artificial materials by creation of different structures. The interface occurring between 
calcium phosphate-based materials and bone was also explained as an amorphous electron-
dense appearance (56). Since all materials, used as bone graft substitutes are considered as 
biocompatible, one can assume that they have no major damaging effects on bone cell 
differentiation or, that cell differentiation and matrix elaboration will not be significantly 
influenced by the presence of the implant material. Each implanted material has a different 
surface reactivity, thus, some materials are considered to be with low surface reactivity, while 
others have high surface reactivity. Materials of low surface reactivity have shown to form the 
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cement line at bone-material interface. But what would happen with materials of high surface 
reactivity? Will they form a “better” bone-material interface? The differences therefore, will 
be in the degree of material surface reactivity. Some investigators (57) have rated calcium 
phosphate-based materials according to their bioactivity in the order: hydroxyapatite, apatite-
wollastonite glass ceramic (AW-GC), Bioglass (BG). All these materials have formed a 
reactive apatite layer on their surfaces, which is variable and dependent on the supply of 
requisite ions. Thus, the thickness of the reactive zone would be expected to be greater with 
the more reactive material. Kitsugi et al. (58) have found that the reaction interfacial zone 
occurs in three steps: a) dissolution of the surface, making the ceramic irregular; b) Ca-P rich 
layer formation on the irregular ceramic surface; c) bone growth toward the smooth surface of 
Ca-P rich layer, completing bone-bonding. With our nice results we have shown already that, 
the surface of designed bioceramics is very active, therefore bone formation occurred directly 
on it, without the presence of such an interfacial zone (Fig. 6.9, 6.11)   
The findings from our animal tests with the usage of HA and BCP silica-based 
ceramics, revealed that in 8 months in the jaw bone the bioceramic is fully degraded and 
resorpted, which led to the formation of a new bone (Fig. 6.19, 6.21). A photograph image of 
the jaw defect after 8 months, proved that it is clinically healed and the only difference 
between the right site of the jaw (no medical intervention) and the left one, which accepted 
our biomaterial, is in its thickness (Fig. 6.18). Basically, no other dissimilarity between the 
right and left site of the jaw can be found. As a misunderstanding can be interpreted the fact, 
which is seen on Figure 6.19 and 6.20. These roentgenographical images taken after 8 months 
(Fig. 6.19) and immediately after the operation (Fig. 6.20) are showing, that perhaps there is 
no difference between the state after 5 weeks and after 8 months. On both pictures one could 
see a certain amount of material, which is filling the cavity of the jaw bone. A logical 
quention is arising after the comparison between both images: Is there a resorption of the 
bioceramic, since it is possible to detect its presence in the defect after 8 months?  
Mandible is the strongest bone of the face, which serves for the reception of the lower 
teeth. It consists of a curved, horizontal portion which is called the body, and two 
perpendicular portions, called rami. The body of the mandible is built up of cancellous bone, 
enclosed within a layer of compact bone. The middle part of the body has a cylindrical cavity, 
filled up with marrow which contain the bloodvessels (59). When the mandible is subjected to 
roentgenographical light, the middle part of the body looks like an empty channel. On Figure 
6.20 the two titanium rods are put to determine the location of the defect, which is filled with 
our bioceramic. But still, on Figure 6.19 there is something in the defect, which looks like the 
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same ceramic. To the best of our knowledge, this is the trabecular bone formed after the 
bioceramic has been degraded within the duration of this study. The spongy (or cancellous) 
bone undergoes resorption around an implant, when a material is drilled into the compact 
bone. The amount of resorption is dependent upon the kind of the implant material and the 
surgical procedure. For hydroxyapatite and some other ceramics, the resorption of the 
cancellous bone is practically zero, due to the higher bioactivity of these materials. When the 
bioceramic is completely resorpted it is followed by deposition of a new bone, which is more 
compact than the surrounding spongy bone. Therefore, what we observed on Figure 6.19 is 
exactely the spongy bone remaining after the ceramic`s degradation and undergoing its own 
resorption to be remodelled and turned up to compact bone. Very similar case we reported 8 
months after the bioceramic has been implanted in the shin bone (Fig. 6. 24b). Thus, with the 
above stated discussion we clarified the misunderstandings related to the roentgenographical 
pictures, which otherwise could lead to wrong interpretation of our results. Different case has 
been reported by Koshino et al. have used sintered HA blocks with 35-48% porosity for the 
treatment of  patients with osteoarthritis. They have implanted the ceramic blocks below the 
upper end of the tibial plateau of patients aged between 66 and 71 years. After 36 months of 
implantation, the biopsy had shown that the density of HA was maintained, which in other 
words means that no absorption of HA had taken place, although they observed bone 
ingrowth into the pores of HA blocks progressively with time (60). For our study we can be 
satisfied with the obtained results, because the newly designed and advanced bioceramics had 
proven good biodegradibility and ability to support new bone formation.   
Due to the equal number of pigs, which received HA and BCP ceramics in their lower 
jaws, it was possible to make statistical explanation of the results. According to it, 
hydroxyapatite silica-based ceramic had shown slightly better results and remained only 0.8 
vol. % in the samples (e.g. nonresorpted), while for biphasic calcium phosphate silica-based 
ceramic this value is 3.4 vol.%. The small difference between the remainings of HA and BCP 
ceramics in the final samples can be neglected. Although, it can be explained with the 
composition of the both ceramics. In HA ceramic the silica percentage is 24 wt. % and the dry 
substance is 76 wt. %. In BCP ceramic the silica is 16 wt. %, and the dry substance 84 wt. % 
(from which 34 wt. % is TCP phase and 50 wt. % is HA phase). So, in HA ceramic there is 
higher silica content than in BCP. It has been shown by many researchers that silica plays an 
important role in bone formation and calcification (25, 61, 62, 63). Our aim thus, was to 
develop a material, which consists of certain amount of silica, and which at the same time is 
osteoconductive. Gibson et al. have proved that silica-substituted HA influences the process 
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of osteoconduction when compared with stoichiometric HA. At the implant interface on Si-
substituted HA, the direct bone apposition exceeded in thickness the same on the 
stoichiometric HA implant (61). One way to explain the higher reactivity of Si-HA is through 
the decrease in grain size in the Si-HA compared to pure HA. These findings are particularly 
important, since grain boundary structure has been shown to have a predominant influence on 
the dissolution behaviour of biological apatites. Thus, the decrease in grain size and increase 
in surface area of the grain boundaries in Si-HA may be playing a significant role in 
increasing the solubility of HA and the subsequent rate at which bone apposes HA ceramic 
(62). Similarly, our results have shown less presence of degrated HA silica-based ceramic 
after 8 months in the biopsies, compared to BCP silica-based ceramic.  
Many authours have reported bone formation around different materals, which were 
tested in vivo. What is interesting to be remarked is that the speed and quantity of bone 
formation of Bioglass (BG) were 8 times greater than AW-GC and 17 times greater than 
hydroxyapatite  in the first week after implantation (63). They explained the obtained results 
as dependent on the amount of silica in the composiion of the material. Bioglass contains 
more silica than apatite-wollastonite glass-ceramic, and even more than hydroxyapatite. We 
assumed, that the fast mineralization and bone formation after 5 weeks of implantation in the 
mandible of mini pigs, are most probably due to the high level of silica in our biphasic 
calcium phosphate silica-based ceramic.    
Another comparative study between TCP, porous HA and natural coral implants in 
surgical defects in mandibular bone of pigs led to the conclusion that, in all cases, bone 
formation started from the bony walls and progressed towards the implanted particles. The 
structure and the composition of these biomaterials had varying but important roles in bone 
conduction. Their influence depends on the experimental model, the site of implantation and 
the delay after implantation (64). Regarding our in vivo study we could state similar with the 
literature findings, which prove the above mentioned. Only in five weeks time we observed 
almost 50 % decrease of the TCP peaks intensity, which is well shown on Fig. 6.7. By 
comparing an X-ray diffraction pattern taken from the edge of the defect with diffraction 
pattern of the bioceramic, it is clear that the intensity of the correspondng TCP peaks is 
different. This leads to the conclusion that, the resorption of our bioceramic (via dissolution of 
the TCP portion) started soon after its implantation, and is almost the same at the edge of the 
defect and in the middle of defect (Fig. 6.7-lower part). TCP dissolution has shown to happen 
independently on the new tissue growth.  
Chapter 6. In vivo examinations - results and discussion                                                                                     98  
 A common characteristic of calcium phosphate biomaterials is their osteoconductivity, 
i.e. a guided bone formation on a biomaterials surface and formation of a chemical bonding 
between the newly formed bone and biomaterials. Recently, it has been found by many 
researchers that calcium phosphate biomaterials can also induce bone formation, i.e. they are 
osteoinductive. The osteinductivity is reported for coral-derived hydroxyapatite ceramic, 
synthetic hydroxyapatite ceramic, biphasic calcium phosphate ceramic, tricalcium phosphate 
ceramic, calcium pyrophosphate ceramic and calcium phosphate cement.  As bone conduction 
by calcium phosphate biomaterials is both material- and animal dependent, in the same 
manner bone induction is material- and animal–dependent. Yuan et al. have reported good 
results for the bone-induction of  hydroxyapatite ceramic in soft tissues, but not for tricalcium 
phosphate ceramic. They explained their findings to be related to the higher solubility of TCP 
in comparison with HA ceramics, which in the case of bone-induction in soft tissues can be 
harmful. Thus, these authors concluded that resorbable calcium phosphate biomaterial is not 
recommended for bone induction (65). Another study by the authors (64) revealed 
information that, when the TCP, porous HA and natural coral implants have been implanted 
in extraskeletal sites, non of them was able to induce bone formation, i.e. HA (in dense and 
porous form), TCP and natural coral are not osteoinductive. The difference between these 
results is to be found in the nature of the materials used, in the implantation site and animal 
model.  
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SUMMARY AND CONCLUSIONS 
 
 
 
Bone is the second most frequently transplanted tissue in humans. In the United States 
alone, it is estimated that over 250 000 operations per year are performed that requires bone 
grafts. The golden standard for graft material is autogenous  bone graft, due to its excellent 
biocompatibility, nontoxicity and high osteogenic potential. However, its limited amounts and 
the complications related to the surgical procedure upon removing, are very big disadvantages 
for surgeons and patients all over the world. Therefore, bioceramics have been created during 
the 60`s and 70`s of  twentieth century as a result of new demand for materials to improve the 
quality of life. This new demand concerns the innovative use of specially designed ceramics 
for the repair and reconstruction of diseased or damaged parts of the body. Our work 
represents a small attempt to contribute to the field of bioceramics: how to improve their 
tissue bonding quality and to understand tissue bonding mechanisms. 
We have designed two different calcium phosphate ceramics, which contain a certain 
amount of silica. One is called hydroxyapatite silica-based ceramic and contains 24 wt % 
silica, and the second one is biphasic calcium phosphate silica-based ceramic with 16 wt % 
silica. The biphasic calcium phosphate (BCP) silica-based ceramic consists of both 
hydroxyapatite (HAP) and tricalcium phosphate (TCP). Hydroxyapatite is found in the 
mineral part of hard tissues, therefore it became a material of choice in the field of 
biomaterials. Tricalcium phosphate on the other side has shown to be highly biodegradable. 
Many researchers have proven that silica has a positive role in the mineralization process, 
which makes it a suitable additive for medical purposes. Hence, we have produced in our 
laboratories a novel bioceramic which had overcome the latest inquiries for highly soluble, 
porous and osteoconductive biomaterial, and may succesfully be used as bone grafting 
substitute material. 
Our HAP and BCP silica-based bioceramics were manufactured by mixing calcium 
phosphate powders with sol-gel-derived silica in an ultrasonic bath. After ripening the mixture 
for a certain time, its viscosity was checked in order to find the optimal time for shaping the 
ceramic. Via extrusion, the ceramic samples were shaped in spaghetti-like form. This form 
optimally allows the loose packing between the crystallites, therefore the bioceramics 
posseses a high level of porosity in the range 60 % to 80 %. From the material point of view, 
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high-porosity can be considered a disadvantage when aiming at load-bearing applications. 
However, one of the factors presumed to govern biodegradation is the degree of porosity. Our 
bioceramic materials have a well expressed porosity in nanometer range, due to the silica gel 
acting as a matrix; in micrometer range, after removing the organic part with heating; and in 
milimeter range due to the unique spaghetti-like shape.  
Another risk factor which influences the porosity level, but strengthens the mechanical 
properties is sintering. We did not sinter our ceramics, for preventing thermal decomposition 
which could occur. The results obtained with X-ray powder diffraction of specimens exposed 
at different temperatures, had shown that temperatures higher than 1000°C are always related 
with decomposition of mono- and biphasic calcium phosphate ceramics to other phases, most 
often to beta-tricalcium phosphate. Therefore, to preserve the phase purity and the starting 
composition of the material we do not recommend heating at temperatures higher than 
1000°C.             
Calcium phosphate ceramics are considered fragile, i.e. they cannot be used for load-
bearing applications. After testing the compressive strength of our specimens heated at 
different temperatures, we have found out that until 600°C the strength remained the same: in 
the range 2.5-3.7 MPa. When heating at temperatures up to 1200°C, the strength changes 
drastically to 50 MPa, which is much more than the compressive strength of cancellous bone 
(1.86 MPa). As stated already, high mechanical strength is always reached after sintering, 
however this leads to thermal decomposition of the specimens. Since the mechanical stability 
was not an aim to achieve, we believe that mechanical strength of 2.5-3.7 MPa is sufficient 
for the purposes of our application. The material characteristics of both ceramics (HA and 
BCP) like porosity, shrinkage, thermal decomposition and compressive strength have shown 
similar results, although the ceramics have slightly different chemical composition.  
The biological performance of our ceramic samples was investigated at the 
Department for Oral and Maxillofacial Surgery and the Department for Orthopaedics at 
University of Rostock. Sixteen, adult Goettinger mini pigs were used for the animal tests. 
Four pigs were used as a control group into which empty defects without material were made. 
In the other twelve animals, defects in the left lower jaws and in the right proximal tibia were 
created. These defects had an overcritical size of 5 cm
3
. The in vivo test was divided into two 
periods: a short-term five weeks period and a long-term eight months period. The short-term 
test period was performed in the mandible of six pigs using both ceramic types. The purpose 
of the short-term in vivo study was to observe material degradation and subsequent bone 
formation. Since calcium phosphate ceramics are bioactive, their degradation is done by the 
Summary and Conclusions                                                                                                                                    101 
activity of osteoclasts, which was observed for our ceramics. In five weeks we found out that 
50 % of the TCP corresponding peak from the biphasic ceramic decreased, a process 
independent on the tissue in-growth. The result proved once again the good choice of 
combining the more soluble tricalcium phosphate with hydroxyapatite, more favourable to 
bone formation. New bone formation usually occurs either around the biomaterial, or directly 
on the material surface. Our study found evidence for both types of bone formation when 
mono- and biphasic calcium phosphate ceramics were implanted in the mandible or tibia of 
mini pigs.  
The long-term in vivo study had shown complete resorption of the bioceramic implant 
and abundant bone formation at the place of medical intervention. In the tibia defect, for 
example, where no mechanical requirements were accomplished, the process of bone 
formation and remodelling had been going on throughout the entire test period. Here it is 
worth mentioning, that in agreement with several other research groups, our results support 
the idea that mechanical strength of calcium phosphate bioceramics improve rapidly in vivo, 
due to bone ingrowth.  
Some statistical procedures have also been carried out. According to these, there is a 
very slight difference between the remaining mono- and biphasic ceramics in the mandible 
after eight months. Leftovers from hydroxyapatite have been found to be 0.8 vol.%, while 3.4 
vol.% biphasic calcium phosphate ceramic remained nondegraded. Similar statistics 
concerning the tibia were not performed, due to the unequal number of tested animals treated 
with hydroxyapatite and biphasic calcium phosphate silica-based ceramics. Nevertheless, on 
both sites of medical intervention (mandible and tibia) a complete new bone formation and 
remodelling with the involvement of our ceramics has been demonstrated. Thus, we believe 
that both hydroxyapatite and biphasic calcium phosphate silica-based ceramics have a very 
promising future as high-performance bone graft substitute materials.  
The good results mentioned in this work have given a background for clinical 
applications, which have started already. In parallel, we will continue working on improving 
the mechanical stability of these bioceramics and on optimizing their manufacturing process 
in order to launch the bioceramics on the market. We are proud to be a part of such an 
interdisciplinary project, aiming to increase the quality of human beings life by designing new 
state-of-the-art bioceramic materials.  
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